Pollen allergy

POLLENALLERG

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J30.10, J30.19 Cause of death: ICD-10 — J30.10, J30.19 2 out of 7 registries used, show all original rules.	9199
4. Check minimum number of events None	9199
5. Include endpoints None	9199
6. Filter based on genotype QC (FinnGen only)	9199

Control definitions (FinnGen only)

Control exclude: ASTHMA_ALLERG

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	POLLENALLERG
CONTROL_EXCLUDE	ASTHMA_ALLERG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J301
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J301
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pollen allergy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	108129	50206	57693
Only index persons	94109	45353	48756
Unadjusted period prevalence (%)
Whole population	1.53	1.44	1.61
Only index persons	1.77	1.67	1.86
Median age at first event (years)
Whole population	14.16	17.11	11.52
Only index persons	16.22	19.74	12.94

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9199	6270	2929
Unadjusted period prevalence (%)	1.87	2.14	1.29
Median age at first event (years)	30.75	31.76	28.61

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8163: Matched controls
80781

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

826.8

323.0

7691

1564

C01CA24

ATC

epinephrine; parenteral

11.3

323.0

2205

2572

V01AA05

ATC

tree pollen; parenteral

29.3

323.0

478

171

R06AX27

ATC

desloratadine; oral

4.9

323.0

4638

16992

XQ800

NOMESCO Finland

Prick test

10.4

323.0

2590

3449

H02AB06

ATC

prednisolone; systemic

3.6

323.0

4550

21115

R03DC03

ATC

montelukast; oral

6.0

323.0

2959

6985

J45

ICD-10 Finland

Asthma

4.4

323.0

1361

3511

XG410

NOMESCO Finland

Flow-volume spirometry

9.1

323.0

743

875

J45.0

ICD-10 Finland

Predominantly allergic asthma

17.7

323.0

3193

2834

R03AK07

ATC

formoterol and budesonide; inhalant

3.2

323.0

2144

8083

L20.0

ICD-10 Finland

Besnier prurigo

4.7

323.0

1678

4249

R06AE07

ATC

cetirizine; oral

5.2

323.0

5883

26954

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

+∞

323.0

312

R06AX13

ATC

loratadine; oral

4.4

323.0

2670

7967

R01AD08

ATC

fluticasone; nasal

4.3

323.0

3971

14596

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

3.5

323.0

3136

12204

R03AC02

ATC

salbutamol; inhalant

5.8

323.0

6396

31193

R03AC03

ATC

terbutaline; inhalant

4.1

323.0

1922

5641

XG474

NOMESCO Finland

Exhalation nntrogen oxide

10.3

323.0

727

761

R03BA02

ATC

budesonide; inhalant

4.7

323.0

2638

7401

R06AE09

ATC

levocetirizine; oral

4.9

323.0

2704

7392

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

5.7

323.0

2907

7138

J45.9

ICD-10 Finland

Asthma, unspecified

5.1

323.0

2542

6632

J30.3

ICD-10 Finland

Other allergic rhinitis

12.8

323.0

1265

1142

S01GX01

ATC

cromoglicic acid; ophthalmic

7.6

323.0

4337

10486

R06AX22

ATC

ebastine; oral

4.3

323.0

2585

7835

J30.19

ICD-10 Finland

Pollen allergy UNS

8.1

323.0

1001

1363

R03BA05

ATC

fluticasone; inhalant

4.3

323.0

2803

8698

Z51.6

ICD-10 Finland

Desensitization to allergens

271.9

323.0

1699

R01AD09

ATC

mometasone; nasal

4.1

323.0

5495

26829

WQ000

NOMESCO Finland

Hyposensibilisation

210.1

323.0

717

R03AK06

ATC

salmeterol and fluticasone; inhalant

4.0

323.0

1533

4409

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

6.3

323.0

2076

4140

R01AD12

ATC

fluticasone furoate; nasal

3.2

323.0

3954

18207

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.5

318.4

897

1514

R01AD05

ATC

budesonide; nasal

4.9

316.9

1154

2643

S01GX02

ATC

levocabastine; ophthalmic

4.9

309.5

1112

2507

R06AX26

ATC

fexofenadine; oral

4.7

308.6

1154

2713

E0000UV

ATC

2.4

293.1

3983

23021

R01AD01

ATC

beclometasone; nasal

3.3

291.7

1713

5968

V01AA02

ATC

grass pollen; systemic

64.3

282.4

331

R96

ICPC

Asthma

4.5

268.0

1060

2616

R01AC01

ATC

cromoglicic acid; nasal

5.6

265.2

843

1641

R01BA52

ATC

pseudoephedrine, combinations; oral

2.5

245.0

2565

12639

R03BA01

ATC

beclometasone; inhalant

3.3

241.4

1410

4822

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

5.8

237.8

729

1352

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

5.4

231.5

745

1463

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

5.7

226.6

699

1304

J45.8

ICD-10 Finland

Mixed asthma

8.2

225.9

530

675

SPAT1267

SPAT

Desensitisation

172.5

225.3

237

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

151.6

223.9

238

R97

ICPC

Allergic rhinitis

7.1

222.8

576

850

R01AD11

ATC

triamcinolone; nasal

3.6

216.5

1080

3247

R03BA08

ATC

ciclesonide; inhalant

3.8

209.1

970

2739

A92

ICPC

Allergy/allergic reaction NOS

5.4

206.3

666

1307

L27.2

ICD-10 Finland

Dermatitis due to ingested food

9.4

203.8

441

489

J31.0

ICD-10 Finland

Chronic rhinitis

3.5

195.1

1000

3058

T78.4

ICD-10 Finland

Allergy, unspecified

4.2

194.6

811

2073

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

191.3

1433

5713

R06.0

ICD-10 Finland

Dyspnoea

2.5

190.3

1831

8428

S01GX08

ATC

ketotifen; ophthalmic

5.1

187.5

631

1295

E000001

ATC

2.3

185.2

2187

11143

R06.2

ICD-10 Finland

Wheezing

4.7

180.3

655

1458

D07AA02

ATC

hydrocortisone; topical

2.5

174.9

1692

7766

XQ802

NOMESCO Finland

Epicutan test

4.6

173.6

650

1491

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.4

171.5

909

2838

H02AB04

ATC

methylprednisolone; systemic

2.8

167.8

1226

4778

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

8.1

167.5

395

504

J01FA10

ATC

azithromycin; systemic

2.0

167.0

5616

42857

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

163.0

2346

12934

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

5.2

154.8

510

1017

J45.1

ICD-10 Finland

Nonallergic asthma

3.4

154.3

814

2523

R06AX12

ATC

terfenadine; oral

4.3

152.8

612

1495

R03AK08

ATC

formoterol and beclometasone; inhalant

5.6

152.7

472

873

E000002

ATC

2.5

148.7

1366

6039

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.5

145.1

751

2288

J30.0

ICD-10 Finland

Vasomotor rhinitis

6.5

140.9

385

608

H02AB07

ATC

prednisone; oral

2.7

140.6

1093

4387

R03AC13

ATC

formoterol; inhalant

4.9

138.5

482

1019

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.6

130.1

639

1862

R01AC02

ATC

levocabastine; nasal

4.7

128.6

466

1027

R05

ICD-10 Finland

Cough

2.2

128.5

1611

8229

R03AC12

ATC

salmeterol; inhalant

5.4

127.8

407

778

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.4

127.4

1220

5475

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

126.6

2259

13305

D07AB08

ATC

desonide; topical

2.6

125.6

1068

4495

D07AC13

ATC

mometasone; topical

1.9

125.3

2192

12809

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

4.2

123.1

501

1237

J01FA09

ATC

clarithromycin; systemic

1.8

123.0

2740

17425

R03BB04

ATC

tiotropium bromide; inhalant

3.9

122.5

550

1484

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

120.0

4561

34205

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

4.8

116.1

412

887

364

Kela drug reimbursment

Allergen extract of birch pollen and allergen extract of grass pollen

290.3

112.9

115

J01AA02

ATC

doxycycline; systemic

1.7

111.3

5268

41680

D07AC01

ATC

betamethasone; topical

1.8

111.3

2388

14879

Z3231

NOMESCO Finland

Registered nurse

1.9

106.9

2154

13101

D11AH01

ATC

tacrolimus; topical

8.6

106.6

240

283

S01GX09

ATC

olopatadine; ophthalmic

4.7

105.4

380

831

J01FA06

ATC

roxithromycin; oral

1.7

101.4

2812

18871

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

100.3

4589

35418

J46

ICD-10 Finland

Status asthmaticus

5.6

100.1

309

568

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

4.8

96.4

342

735

DHB50

NOMESCO Finland

Turbinoplasty

4.4

91.4

354

831

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

6.6

90.4

244

378

R02

ICPC

Shortness of breath/dyspnoea

2.3

89.8

893

4032

R03DA04

ATC

theophylline; systemic, rectal

4.4

89.5

341

787

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

89.5

1562

8941

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

89.4

2411

15903

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.0

89.2

378

965

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.1

87.9

1099

5514

J34.2

ICD-10 Finland

Deviated nasal septum

3.2

87.0

497

1613

R03BC01

ATC

cromoglicic acid; inhalant

5.2

83.8

273

534

S01GX04

ATC

nedocromil; ophthalmic

5.6

82.4

250

450

R06AX18

ATC

acrivastine; oral

4.7

82.4

294

635

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.1

80.3

464

1517

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.5

79.5

390

1127

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

7.2

78.7

198

278

R06AX11

ATC

astemizole; oral

3.3

77.5

421

1315

D02AX

ATC

Other emollients and protectives

3.2

76.0

427

1368

A02BC05

ATC

esomeprazole; systemic

1.6

75.6

2469

16999

A02BC02

ATC

pantoprazole; systemic

1.5

74.1

3984

30948

R03CC02

ATC

salbutamol; systemic

1.9

73.8

1148

6254

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

72.0

2207

14896

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.1

71.8

425

1411

R03BC03

ATC

nedocromil; inhalant

2.7

70.9

527

2024

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

70.9

1264

7224

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

4.1

70.5

287

706

J33.8

ICD-10 Finland

Other polyp of sinus

5.5

70.5

216

394

E000007

ATC

2.5

70.3

598

2478

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

8.6

70.1

157

184

D02AE01

ATC

carbamide; topical

2.5

68.6

581

2402

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

4.3

68.0

267

635

L20

ICD-10 Finland

Atopic dermatitis

3.1

67.7

407

1366

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

63.7

1570

9914

E000006

ATC

2.4

61.4

561

2410

N05BB01

ATC

hydroxyzine; systemic

2.3

59.8

573

2519

J01DB01

ATC

cefalexin; oral

1.5

57.7

6335

55923

XQ899

NOMESCO Finland

Other assessment of skin

13.1

57.4

103

S01GX06

ATC

emedastine; ophthalmic

5.7

57.1

169

296

J01DA01

ATC

[U] cefalexin; systemic

1.5

57.0

4459

36614

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

55.2

2801

21018

SPAT1058

SPAT

PEF monitoring instruction

2.2

55.1

580

2666

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

54.4

1856

12711

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

3.8

53.3

234

616

D07CC01

ATC

betamethasone and antibiotics; topical

1.9

53.3

911

5094

J02AC01

ATC

fluconazole; systemic

1.5

53.2

3013

23078

G47.3

ICD-10 Finland

Sleep apnoea

1.7

53.1

1137

6843

XG405

NOMESCO Finland

Education on PEF monitoring

5.7

52.5

157

279

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

52.3

640

3144

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.1

52.0

301

984

J01CA04

ATC

amoxicillin; systemic

1.6

51.5

6893

62501

M25.5

ICD-10 Finland

Pain in joint

1.5

51.2

2006

14159

J33.0

ICD-10 Finland

Polyp of nasal cavity

4.0

51.2

212

530

D11AH02

ATC

pimecrolimus; topical

9.0

50.5

109

121

UDM02

NOMESCO Finland

Sinoscopy

3.9

50.4

216

557

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

49.7

1688

11506

E000003

ATC

2.5

49.7

413

1683

R03AK11

ATC

formoterol and fluticasone; inhalant

3.7

49.6

224

605

M01AE02

ATC

naproxen; oral, rectal

1.4

49.0

4474

37317

S01GX05

ATC

lodoxamide; ophthalmic

5.6

48.9

148

267

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

48.7

2476

18461

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

7.3

48.1

118

161

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

48.1

1364

8872

R74

ICPC

Upper respiratory infection acute

1.4

47.9

2926

22609

M03BX02

ATC

tizanidine; oral

1.4

47.1

4239

35146

L50.0

ICD-10 Finland

Allergic urticaria

3.0

47.0

287

970

J20

ICD-10 Finland

Acute bronchitis

2.0

46.9

656

3398

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

9.2

46.1

106

R03DC01

ATC

zafirlukast; oral

6.0

45.5

130

219

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.4

45.4

140

259

A02BC01

ATC

omeprazole; systemic

1.6

44.5

1520

10336

L50.8

ICD-10 Finland

Other urticaria

3.7

44.4

204

559

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.6

44.4

1556

10650

D11AX14

ATC

[U] tacrolimus; topical

8.3

44.3

100

120

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

44.3

373

1533

XG430

NOMESCO Finland

Spiroegometry

8.8

44.0

109

N02BE01

ATC

paracetamol; systemic, rectal

1.4

43.5

5952

52792

J01FA15

ATC

telithromycin; oral

1.9

43.5

665

3560

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

42.8

1191

7682

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

5.0

42.2

139

277

R51.80

ICD-10 Finland

Headache

1.6

42.0

1289

8529

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

5.0

41.8

138

276

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

41.6

321

1257

J37.0

ICD-10 Finland

Chronic laryngitis

3.2

40.7

224

707

M79.1

ICD-10 Finland

Myalgia

1.7

39.9

950

5861

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

4.2

39.9

155

367

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

39.7

2844

22405

M01AH05

ATC

etoricoxib; oral

1.4

39.7

3705

30536

A02BC03

ATC

lansoprazole; oral

1.5

39.2

1433

9864

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.7

37.9

963

6046

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

37.5

1103

7195

M79.6

ICD-10 Finland

Pain in limb

1.4

37.5

2250

17127

D07AD01

ATC

clobetasol; topical

1.7

37.5

864

5277

A02BC04

ATC

rabeprazole; oral

1.9

37.4

546

2868

J30

ICD-10 Finland

Vasomotor and allergic rhinitis

3.3

37.4

199

614

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

37.0

953

6004

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

36.5

583

3165

J01DA06

ATC

[U] cefuroxime; systemic

1.6

35.9

948

6012

N02AX02

ATC

tramadol; systemic, rectal

1.4

35.8

2179

16600

G44.2

ICD-10 Finland

Tension-type headache

1.6

35.5

1018

6592

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

4.5

35.3

128

284

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

34.9

498

2592

J01FF01

ATC

clindamycin; systemic

1.5

34.9

1637

11851

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

34.9

2536

19912

R01AC07

ATC

nedocromil; nasal

8.4

34.6

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

34.3

1197

8129

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

34.1

1780

13153

R05FB02

ATC

cough suppressants and expectorants

1.4

33.6

1902

14267

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.8

33.5

631

3619

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

5.5

33.5

101

183

R06AE08

ATC

5.0

33.1

109

219

A07AA02

ATC

nystatin; oral

2.3

32.9

311

1357

R03BB01

ATC

ipratropium bromide; inhalant

3.6

32.9

151

416

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

4.2

32.8

129

310

R05

ICPC

Cough

1.4

32.8

1623

11858

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

32.6

1260

8746

R06.5

ICD-10 Finland

Mouth breathing

1.8

32.4

543

2997

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.8

32.2

210

746

L50.9

ICD-10 Finland

Urticaria, unspecified

2.2

31.8

344

1597

J32.4

ICD-10 Finland

Chronic pansinusitis

4.0

31.8

132

334

ZXC60

NOMESCO Finland

Application of heat

3.7

31.5

144

395

D11AX15

ATC

[U] pimecrolimus; topical

10.1

31.5

XQ801

NOMESCO Finland

Intracutantest

8.1

31.3

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

31.0

1247

8721

R42

ICD-10 Finland

Dizziness and giddiness

1.5

31.0

1033

6926

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

3.4

30.8

151

439

J01

ICD-10 Finland

Acute sinusitis

2.0

30.8

410

2079

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

30.7

1141

7846

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.2

30.6

168

532

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

30.2

1031

6947

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

29.9

1828

13851

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

29.7

656

3946

N06AX11

ATC

mirtazapine; oral

1.4

29.1

1907

14622

R53

ICD-10 Finland

Malaise and fatigue

1.5

29.1

1271

9033

R01AC03

ATC

azelastine; nasal

8.1

28.6

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

8.9

28.5

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

28.4

1810

13796

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

28.4

830

5385

J01DC02

ATC

cefuroxime; systemic

1.9

28.3

433

2310

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

28.3

480

2657

49300

ICD-8 Finland

Asthma, bronchiale

3.5

28.1

133

377

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

7.6

28.1

J05AB01

ATC

aciclovir; systemic

1.4

28.0

1301

9357

ZX101

NOMESCO Finland

Sublingual

77.1

27.6

J01MA12

ATC

levofloxacin; systemic

1.6

27.4

816

5313

N03AX16

ATC

pregabalin; oral

1.5

27.4

1168

8253

E000004

ATC

2.8

27.3

179

637

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

27.2

643

3939

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

4.3

27.2

103

240

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

27.2

2381

19078

A02BA02

ATC

ranitidine; systemic

1.6

27.0

807

5258

X58

ICD-10 Finland

Exposure to other specified factors

1.5

26.9

1011

6947

WZC30

NOMESCO Finland

Teaching

1.6

26.9

675

4210

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

26.8

1528

11403

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.5

26.8

214

856

J30.2

ICD-10 Finland

Other seasonal allergic rhinitis

7.0

26.8

L01

ICPC

Neck symptom/complaint

1.5

26.7

955

6494

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

26.6

654

4052

SPAT1057

SPAT

Peak expiratory flow measurement

2.8

26.3

171

607

J01FA01

ATC

erythromycin; systemic

1.4

26.0

1204

8640

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

5.5

25.8

139

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

25.8

1869

14516

XQ830

NOMESCO Finland

Exposure to foodstuff

9.8

25.7

Z01.2

ICD-10 Finland

Dental examination

1.3

25.5

3383

28656

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

25.5

362

1882

J01MA14

ATC

moxifloxacin; systemic

1.8

25.4

439

2443

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

25.2

536

3187

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

25.2

1274

9291

J01AA04

ATC

lymecycline; systemic

1.5

25.2

1091

7723

R01AD

ATC

Corticosteroids

4.7

25.1

186

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

4.5

25.0

200

J05AB11

ATC

valaciclovir; oral

1.6

25.0

762

4988

J02AC02

ATC

itraconazole; systemic

1.5

24.8

980

6802

XQ820

NOMESCO Finland

Exposure to medicinal substance

5.9

24.7

119

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.5

24.7

841

5654

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

24.6

560

3396

SPAT1325

SPAT

Vaccination

1.3

24.5

2071

16450

WX002

NOMESCO Finland

Sedation and analgesia

1.5

24.4

957

6631

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

24.3

789

5238

S87

ICPC

Dermatitis/atopic eczema

2.3

24.2

238

1057

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

23.6

1638

12606

R75

ICPC

Sinusitis acute/chronic

1.9

23.6

355

1887

ZXA10

NOMESCO Finland

Bilateral

1.5

23.6

964

6737

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

23.2

1211

8875

N03AX12

ATC

gabapentin; oral

1.5

23.1

762

5076

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

23.1

431

2460

L20.8

ICD-10 Finland

Other atopic dermatitis

3.5

23.1

109

310

H10.4

ICD-10 Finland

Chronic conjunctivitis

4.3

23.0

204

K07.60

ICD-10 Finland

Snapping jaw

1.8

22.9

428

2443

Z3226

NOMESCO Finland

Physiotherapist

1.4

22.9

1113

8048

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

22.8

524

3187

M02AA07

ATC

piroxicam; topical

1.3

22.7

1634

12637

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.8

22.6

250

DHB20

NOMESCO Finland

Polypectomy of internal nose

4.0

22.6

231

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

22.6

2338

19074

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

4.9

22.5

150

A03FA02

ATC

cisapride; oral, rectal

1.9

22.4

337

1791

R49.08

ICD-10 Finland

Other specified dysphonia

2.9

22.3

136

465

R09

ICPC

Sinus symptom/complaint

1.6

22.3

619

3956

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

22.3

200

851

Z58.8

ICD-10 Finland

Other problems related to physical environment

14.7

22.3

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

22.1

1264

9407

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

22.0

2342

19158

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

4.8

22.0

150

SPAT1310

SPAT

Counselling related to known health issue

1.3

21.8

2249

18314

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

21.8

751

5055

L03

ICPC

Low back symptom/complaint

1.3

21.7

1549

11952

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

21.7

223

1014

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

8.0

21.6

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

4.7

21.5

154

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

21.2

2246

18339

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

4.0

21.2

211

K30

ICD-10 Finland

Functional dyspepsia

1.6

21.0

584

3735

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

20.9

629

4098

L50.3

ICD-10 Finland

Dermatographic urticaria

2.6

20.9

153

584

J01MA02

ATC

ciprofloxacin; systemic

1.3

20.8

1904

15233

SPAT1059

SPAT

Spirometry at the office

2.0

20.6

252

1236

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.6

20.5

565

3603

J35.2

ICD-10 Finland

Hypertrophy of adenoids

1.8

20.3

371

2105

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

20.3

524

3286

J04.0

ICD-10 Finland

Acute laryngitis

1.8

20.2

355

1987

C09CA06

ATC

candesartan; oral

1.4

20.2

977

7041

N06AB10

ATC

escitalopram; oral

1.3

20.1

1564

12212

D06BX01

ATC

metronidazole; topical

1.6

20.1

580

3740

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

4.6

20.0

148

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

20.0

3062

26146

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

20.0

557

3562

Z2221

NOMESCO Finland

Medical doctor

1.3

19.9

1826

14604

A04

ICPC

Weakness/tiredness general

1.4

19.9

901

6416

R21

ICPC

Throat symptom/complaint

1.3

19.8

2081

16950

M01AB05

ATC

diclofenac; systemic, rectal

1.2

19.6

4061

35856

R29

ICPC

Respiratory symptom/complaint other

1.7

19.5

416

2476

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

19.5

982

7128

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.0

19.5

261

1330

N05CF01

ATC

zopiclone; oral

1.3

19.4

1421

10991

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

19.3

536

3426

D09AB01

ATC

zinc bandage without supplements; topical

3.0

19.3

111

366

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

19.3

660

4430

EMB10

NOMESCO Finland

Tonsillectomy

1.5

19.3

619

4097

N06AX21

ATC

duloxetine; oral

1.5

19.3

644

4302

SPAT1311

SPAT

Counselling and guidance related to occupational health

2.0

19.0

250

1265

D07CB01

ATC

triamcinolone and antibiotics; topical

2.7

19.0

127

463

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

18.8

599

3953

R01BA01

ATC

phenylpropanolamine; oral

1.9

18.8

300

1629

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

18.7

1515

11891

X57

ICD-10 Finland

Unspecified privation

2.5

18.7

143

563

R04

ICPC

Breathing problem other

2.2

18.6

200

931

J01AA07

ATC

tetracycline; systemic

1.4

18.6

1148

8634

S29

ICPC

Skin symptom/complaint other

1.4

18.6

963

7026

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

5.9

18.3

R06AX25

ATC

mizolastine; oral

7.7

18.3

R01AX03

ATC

ipratropium bromide; nasal

3.0

18.0

106

356

M79.7

ICD-10 Finland

Fibromyalgia

2.0

18.0

229

1142

L15

ICPC

Knee symptom/complaint

1.4

18.0

1165

8827

D07AC14

ATC

methylprednisolone aceponate; topical

1.9

17.9

282

1526

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.9

17.8

270

1441

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

17.8

611

4105

EMB30

NOMESCO Finland

Adenotomy

1.6

17.8

470

2964

XG432

NOMESCO Finland

Cold exponation and spirometry

9.0

17.7

S18

ICPC

Laceration/cut

1.3

17.7

2188

18146

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

17.6

3566

31259

395

Kela drug reimbursment

Dupilumab

19.8

17.6

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

17.6

243

1252

M54.5

ICD-10 Finland

Low back pain

1.3

17.5

2074

17103

D82

ICPC

Teeth/gum disease

1.2

17.5

2752

23464

H01

ICPC

Ear pain/earache

1.4

17.4

921

6738

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

17.4

742

5211

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

17.4

907

6620

R51

ICD-10 Finland

Headache

1.6

17.3

419

2584

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

17.3

1422

11166

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

5.9

17.3

A06AC51

ATC

ispaghula, combinations; systemic

1.9

17.2

250

1313

R83

ICPC

Respiratory infection other

1.3

17.0

2309

19339

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

3.3

17.0

250

N05BA04

ATC

oxazepam; oral

1.3

17.0

1414

11119

M54

ICD-10 Finland

Dorsalgia

1.4

16.9

720

5061

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

16.8

1012

7565

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

16.8

277

1522

R03BA07

ATC

mometasone; inhalant

3.6

16.8

211

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

16.8

1113

8458

L13

ICPC

Hip symptom/complaint

1.5

16.8

620

4233

J31.1

ICD-10 Finland

Chronic nasopharyngitis

3.9

16.8

177

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.5

16.7

128

505

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.5

16.7

134

543

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

1.7

16.7

335

1958

J01MA06

ATC

norfloxacin; oral

1.5

16.6

622

4257

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

16.6

5637

52017

WX722

NOMESCO Finland

PEEP

2.1

16.5

191

919

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

6.8

16.5

A01AB09

ATC

miconazole; local oral

1.6

16.4

435

2744

505

Kela drug reimbursment

Allergy to cow's milk in infants

5.5

16.4

H10

ICD-10 Finland

Conjunctivitis

1.6

16.2

472

3051

N05CF02

ATC

zolpidem; oral

1.4

16.2

958

7146

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

16.1

282

1581

N06AB04

ATC

citalopram; systemic

1.3

16.1

1150

8839

UDC00

NOMESCO Finland

Ear microscopy

1.6

15.9

430

2728

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

15.9

525

3495

J33.9

ICD-10 Finland

Nasal polyp, unspecified

3.7

15.9

186

N02CC03

ATC

zolmitriptan; nasal, oral

1.6

15.8

403

2524

344

Kela drug reimbursment

Omalizumab

12.1

15.7

H03AA01

ATC

levothyroxine sodium; systemic

1.3

15.6

1198

9300

R07

ICPC

Sneezing/nasal congestion

1.5

15.6

599

4123

L12

ICPC

Hand/finger symptom/complaint

1.4

15.5

984

7417

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

8.6

15.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

15.5

336

2011

H02

ICPC

Hearing complaint

1.6

15.5

371

2284

A98

ICPC

Health maint/preventive medicine

1.7

15.5

7925

76895

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.7

15.3

305

1782

W84

ICD-10 Finland

Unspecified threat to breathing

6.1

15.2

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

15.2

468

3068

C05AA08

ATC

fluocortolone; rectal, topical

1.5

15.2

624

4353

L17

ICPC

Foot/toe symptom/complaint

1.3

15.2

1452

11619

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.4

15.2

657

4632

E0001A1

ATC

1.9

15.1

217

1137

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.2

15.1

247

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

15.0

5499

50804

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.2

15.0

237

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.0

15.0

180

880

UJF32

NOMESCO Finland

Coloscopy

1.3

15.0

1041

7957

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

14.9

474

3129

R4110

NOMESCO Finland

Physiotherapy

1.3

14.9

1382

11005

N01

ICPC

Headache

1.3

14.9

1137

8812

Z71.8

ICD-10 Finland

Other specified counselling

1.3

14.9

1711

14009

R05DA01

ATC

ethylmorphine; oral

1.6

14.9

384

2411

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

14.8

911

6831

SPAT1312

SPAT

General health counselling

1.2

14.8

2484

21232

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

14.8

3194

28009

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.9

14.7

295

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.6

14.7

369

2300

D07XB05

ATC

dexamethasone, combinations; topical

2.2

14.6

151

691

T78.3

ICD-10 Finland

Angioneurotic oedema

2.8

14.6

331

Z01.7

ICD-10 Finland

Laboratory examination

1.4

14.6

638

4507

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

4.0

14.5

141

SPAT1263

SPAT

Sampling

1.2

14.5

2933

25544

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

5.3

14.4

R00.2

ICD-10 Finland

Palpitations

1.5

14.4

436

2847

K07.61

ICD-10 Finland

Cracking jaw joint

2.1

14.4

167

808

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

14.4

763

5580

N06AA09

ATC

amitriptyline; systemic

1.6

14.3

389

2476

L08

ICPC

Shoulder symptom/complaint

1.4

14.2

884

6639

D11AH05

ATC

dupilumab; topical

18.9

14.1

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.1

13.9

156

742

ZX112

NOMESCO Finland

Subcutaneous

2.4

13.9

113

462

L16

ICPC

Ankle symptom/complaint

1.4

13.9

706

5122

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

3.0

13.9

266

M01AX17

ATC

nimesulide; oral

1.4

13.9

882

6645

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

13.8

2149

18188

F32

ICD-10 Finland

Depressive episode

1.5

13.8

413

2687

D07AB01

ATC

clobetasone; topical

2.0

13.8

184

938

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

13.8

508

3464

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

3.1

13.8

242

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

13.8

2441

20948

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.2

13.8

132

586

R01AD04

ATC

flunisolide; nasal

4.4

13.7

111

AA40B

NOMESCO Finland

6.8

13.7

R07.0

ICD-10 Finland

Pain in throat

1.5

13.6

482

3260

R51.81

ICD-10 Finland

Facial pain NOS

2.2

13.6

139

636

XQ817

NOMESCO Finland

9.6

13.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

13.4

371

2371

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

13.4

2362

20245

M02AA10

ATC

ketoprofen; topical

1.4

13.4

686

4986

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

4.3

13.3

110

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

2.4

13.3

115

486

A07EB01

ATC

cromoglicic acid; oral

25.5

13.3

D10AX03

ATC

azelaic acid; topical

1.4

13.2

714

5237

A12

ICPC

ALLERGY/ALLERGIC REACTION

4.0

13.2

130

J35.1

ICD-10 Finland

Hypertrophy of tonsils

1.8

13.1

222

1231

G43

ICD-10 Finland

Migraine

1.5

13.1

430

2859

H10.5

ICD-10 Finland

Blepharoconjunctivitis

2.3

13.1

122

534

J47

ICD-10 Finland

Bronchiectasis

3.4

13.1

186

GD1AA

SPAT

1.5

13.1

468

3173

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

8.9

13.1

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

13.1

369

2368

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

13.0

545

3813

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

13.0

301

1839

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

12.9

625

4497

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

12.9

425

2829

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

12.9

2719

23693

XG488

NOMESCO Finland

Other provokation of respiratroy tract

9.9

12.8

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

12.8

379

2462

J32.1

ICD-10 Finland

Chronic frontal sinusitis

4.6

12.8

S01AD03

ATC

aciclovir; ophthalmic

1.9

12.8

176

908

J01DA08

ATC

[U] cefaclor; oral

1.3

12.8

1192

9491

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.7

12.8

279

1677

F29

ICPC

Eye symptom/complaint other

1.5

12.5

494

3419

N05BA12

ATC

alprazolam; oral

1.5

12.5

491

3394

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.6

12.5

290

1772

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

12.5

278

1679

SPAT1283

SPAT

Restricted health certificate

1.2

12.5

1932

16314

SPAT1324

SPAT

Screening procedure

0.8

12.4

853

10669

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

12.3

1470

12059

R49.01

ICD-10 Finland

Functional dysphonia

2.0

12.3

153

761

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

12.2

361

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

12.2

636

4634

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

12.2

458

3140

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

12.2

345

2219

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

12.1

1969

16698

C07AA05

ATC

propranolol; systemic

1.3

11.9

1242

10022

L02

ICPC

Back symptom/complaint

1.4

11.9

627

4580

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

11.9

275

1680

J39.8

ICD-10 Finland

Other specified diseases of upper respiratory tract

4.8

11.8

N02CC04

ATC

rizatriptan; oral

1.5

11.7

418

2830

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.2

11.7

101

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.6

11.7

282

1741

J32

ICD-10 Finland

Chronic sinusitis

3.6

11.7

145

R35

ICD-10 Finland

Polyuria

1.7

11.7

231

1349

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

3.6

11.7

140

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

11.7

873

6734

R03DX05

ATC

omalizumab; parenteral

10.4

11.6

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

11.6

486

3403

N06AB03

ATC

fluoxetine; oral

1.3

11.6

730

5490

SPAT1229

SPAT

Assessment of need for aid

1.7

11.6

239

1416

N06AX16

ATC

venlafaxine; oral

1.3

11.6

916

7124

ZXE00

NOMESCO Finland

One hour or less

1.2

11.6

2526

22030

SPAT1153

SPAT

Removal of sutures

1.2

11.5

1444

11903

P01AB01

ATC

metronidazole; oral, rectal

1.2

11.5

2340

20270

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

11.5

708

5303

R13

ICD-10 Finland

Dysphagia

1.7

11.5

239

1419

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

11.4

142

708

M01AC06

ATC

meloxicam; systemic, rectal

1.2

11.4

1705

14326

TQW80

NOMESCO Finland

Local dermatologic skincare

2.1

11.4

131

635

H92.0

ICD-10 Finland

Otalgia

1.5

11.4

371

2465

SPAT1104

SPAT

Monitoring of emergency patient

1.6

11.4

296

1866

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.4

11.2

380

A99

ICPC

Disease/condition unspecnature/site

1.5

11.2

391

2640

J01MA01

ATC

ofloxacin; systemic

1.6

11.1

295

1868

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

8.8

11.1

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

11.1

637

4720

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

11.1

249

1507

S88

ICPC

Dermatitis contact/allergic

2.0

11.1

135

669

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

11.1

532

3822

R52.2

ICD-10 Finland

Other chronic pain

1.8

11.0

174

948

SPAT1211

SPAT

Application of soft bandage

1.4

11.0

541

3903

D07XC01

ATC

betamethasone, combinations; topical

1.4

11.0

511

3650

M24.2

ICD-10 Finland

Disorder of ligament

2.3

10.9

100

438

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

10.9

376

2530

A02BA04

ATC

nizatidine; systemic

1.7

10.9

244

1478

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

10.9

2067

17770

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.4

10.9

440

3062

ZXD20

NOMESCO Finland

Day surgery

1.3

10.9

700

5281

R12

ICD-10 Finland

Heartburn

1.5

10.8

379

2558

B37.0

ICD-10 Finland

Candidal stomatitis

3.0

10.7

194

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.2

10.7

1486

12377

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.7

10.7

230

1377

R50.9

ICD-10 Finland

Fever, unspecified

1.3

10.7

851

6620

A01

ICPC

Pain general/multiple sites

1.5

10.7

376

2542

M01AH02

ATC

rofecoxib; oral

1.5

10.7

409

2812

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

10.7

1587

13314

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

3.0

10.6

190

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

10.6

449

3153

R07.3

ICD-10 Finland

Other chest pain

1.5

10.6

395

2701

P06

ICPC

Sleep disturbance

1.4

10.6

625

4653

SPAT1260

SPAT

Consultation of another employee

1.3

10.6

998

7941

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

10.6

324

2123

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

10.6

426

2961

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

10.5

361

2430

D06BB03

ATC

aciclovir; topical

1.6

10.5

248

1527

Z00.0

ICD-10 Finland

General medical examination

1.3

10.5

1119

9044

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

10.5

619

4607

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

10.5

372

2523

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.1

10.4

117

562

K08.80

ICD-10 Finland

Toothache NOS

1.4

10.4

526

3812

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

10.4

380

2586

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

10.4

182

1027

B02AA02

ATC

tranexamic acid; systemic

1.3

10.4

832

6480

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.4

10.4

544

3969

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.5

10.4

310

2024

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.6

10.3

262

1643

D01

ICPC

Abdominal pain/cramps general

1.3

10.3

840

6558

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

10.3

229

1386

WQ007

NOMESCO Finland

7.6

10.3

N06AB06

ATC

sertraline; oral

1.3

10.3

751

5776

C08DA01

ATC

verapamil; systemic

1.9

10.2

141

732

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

2.3

10.2

381

N06AX12

ATC

bupropion; oral

1.4

10.2

502

3627

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

10.1

646

4867

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

10.1

403

2795

SPAT1254

SPAT

Administration of medicine

1.3

10.1

899

7099

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

10.1

2467

21672

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.4

10.1

425

2985

DM1QA

SPAT

1.8

10.0

159

869

H01.0

ICD-10 Finland

Blepharitis

1.5

9.9

333

2229

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

9.9

4386

40376

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

4.2

9.9

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

9.9

229

1404

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

9.9

420

2953

J01DC04

ATC

cefaclor; oral

2.1

9.9

112

540

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

9.9

979

7838

M35.7

ICD-10 Finland

Hypermobility syndrome

2.0

9.9

121

602

A07DA03

ATC

loperamide; oral

2.0

9.8

117

577

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.0

9.8

116

568

DHB40

NOMESCO Finland

Conchotomy

6.6

9.8

N02CC07

ATC

frovatriptan; oral

1.5

9.8

316

2100

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.6

9.7

230

1418

XG466

NOMESCO Finland

Sleep oxymetry

2.0

9.7

118

587

R06.4

ICD-10 Finland

Hyperventilation

2.0

9.6

117

580

D01AA02

ATC

natamycin; topical

2.0

9.6

113

555

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

9.6

842

6637

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

9.6

2701

23982

L11

ICPC

Wrist symptom/complaint

1.4

9.6

557

4136

M54.2

ICD-10 Finland

Cervicalgia

1.5

9.5

370

2553

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

9.5

297

1959

N06AX26

ATC

vortioxetine; oral

1.4

9.5

408

2875

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.2

9.5

423

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

9.5

6750

64466

S06.0

ICD-10 Finland

Concussion

1.3

9.5

640

4866

M54.1

ICD-10 Finland

Radiculopathy

1.7

9.4

171

978

F03

ICPC

Eye discharge

1.4

9.4

408

2878

DPA30

NOMESCO Finland

Sphenotomy

3.6

9.4

114

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

9.4

554

4122

F71

ICPC

Conjunctivitis allergic

4.0

9.4

H93.1

ICD-10 Finland

Tinnitus

1.5

9.4

269

1740

N17

ICPC

Vertigo/dizziness

1.4

9.3

501

3675

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

9.3

105

506

H60.8

ICD-10 Finland

Other otitis externa

1.8

9.2

153

851

TQC05

NOMESCO Finland

Puncture of skin of upper limb

7.9

9.2

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.3

9.2

684

5270

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.6

9.2

220

1363

G43.3

ICD-10 Finland

Complicated migraine

1.9

9.1

136

728

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

9.1

623

4746

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

2.5

9.1

265

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

9.1

361

2506

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.4

9.1

487

3573

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.7

9.0

188

1121

L50.2

ICD-10 Finland

Urticaria due to cold and heat

4.0

9.0

J32.8

ICD-10 Finland

Other chronic sinusitis

4.2

9.0

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.5

8.9

276

1817

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

8.9

414

2960

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

8.8

754

5921

N04BC05

ATC

pramipexole; oral

1.6

8.8

229

1448

SPAT1268

SPAT

Allergy testing

3.9

8.8

D06

ICPC

Abdominal pain localized other

1.4

8.8

513

3815

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.4

8.8

363

2542

A02BX02

ATC

sucralfate; oral

1.9

8.8

121

632

M22.4

ICD-10 Finland

Chondromalacia patellae

1.6

8.7

207

1280

N39.3

ICD-10 Finland

Stress incontinence

1.5

8.7

284

1892

R11

ICD-10 Finland

Nausea and vomiting

1.4

8.7

468

3432

J01DB05

ATC

cefadroxil; oral

1.6

8.7

243

1563

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.2

8.7

401

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.6

8.6

244

1572

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

8.6

560

4229

L60.0

ICD-10 Finland

Ingrowing nail

1.5

8.6

249

1616

J39.3

ICD-10 Finland

Upper respiratory tract hypersensitivity reaction, site unspecified

5.3

8.6

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.5

8.6

255

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

8.6

548

4131

G01AF05

ATC

econazole; vaginal

1.4

8.6

402

2877

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

2.0

8.5

109

555

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.4

8.5

448

3273

J01EA01

ATC

trimethoprim; systemic

1.2

8.5

1334

11229

SBB10

NOMESCO Finland

Teeth copy

1.3

8.5

655

5073

A01AB04

ATC

amphotericin B; local oral

1.8

8.5

142

791

R03DX09

ATC

mepolizumab; parenteral

16.1

8.5

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.3

8.5

543

4098

S82

ICPC

Naevus/mole

1.3

8.4

705

5520

M75

ICD-10 Finland

Shoulder lesions

1.7

8.4

184

1111

C07AB07

ATC

bisoprolol; oral

1.2

8.4

1526

13023

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.9

8.4

120

635

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.9

8.4

110

566

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

1.7

8.4

152

869

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

8.4

216

1363

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

2.6

8.3

223

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

8.3

355

2502

N03AX09

ATC

lamotrigine; oral

1.4

8.3

352

2477

D01AC02

ATC

miconazole; topical

1.5

8.3

285

1924

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

6.6

8.3

L86

ICPC

Back syndrome with radiating pain

1.5

8.2

241

1569

WX320

NOMESCO Finland

Spinalanesthesy

1.2

8.2

961

7843

D19

ICPC

Teeth/gum symptom/complaint

1.2

8.2

1854

16123

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

5.7

8.2

UJF92

NOMESCO Finland

Capsular endoscopy

1.8

8.2

132

729

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

8.1

240

1566

297

Kela drug reimbursment

14.3

8.1

3028

Kela drug reimbursment

Mepolizumab

14.3

8.1

WX110

NOMESCO Finland

Local anesthesy

1.1

8.1

5226

49084

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

5.9

8.0

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.5

8.0

254

1683

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.7

8.0

192

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.2

8.0

947

7734

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

8.0

391

2824

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

3.5

8.0

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

2.3

8.0

309

D01AC03

ATC

econazole; topical

1.6

8.0

213

1356

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

2.1

7.9

384

S01AA13

ATC

fusidic acid; ophthalmic

1.6

7.9

213

1361

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.4

7.9

419

3065

SPAT1043

SPAT

Audiometry

1.4

7.9

347

2457

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

1.8

7.9

139

791

XF402

NOMESCO Finland

ECG with work load test

1.4

7.9

330

2316

A03

ICPC

Fever

1.2

7.9

1399

11907

H02BX01

ATC

methylprednisolone, combinations; systemic

1.8

7.9

137

777

N07CA01

ATC

betahistine; oral

1.6

7.9

217

1395

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.1

7.9

127

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.0

7.8

101

515

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.3

7.8

836

6749

AA1AD

NOMESCO Finland

CT of head and brain

1.3

7.8

820

6610

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

7.8

763

6097

R60.0

ICD-10 Finland

Localized oedema

1.4

7.7

361

2586

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

7.7

408

2987

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

9.3

7.7

A97

ICPC

No disease

1.2

7.7

960

7886

M54.8

ICD-10 Finland

Other dorsalgia

1.6

7.7

204

1299

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

7.7

224

1458

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.7

7.7

163

980

S80.0

ICD-10 Finland

Contusion of knee

1.4

7.7

399

2913

G01AA10

ATC

clindamycin; vaginal

1.2

7.6

886

7223

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

7.6

300

2081

R04.0

ICD-10 Finland

Epistaxis

1.5

7.6

225

1468

DHA10

NOMESCO Finland

Biopsy of cavity of nose

3.1

7.6

130

N76.0

ICD-10 Finland

Acute vaginitis

1.3

7.6

499

3780

L26

ICD-10 Finland

Exfoliative dermatitis

7.3

7.6

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

7.6

811

6549

XF404

NOMESCO Finland

Ambulatory ECG

1.4

7.5

332

2357

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

7.5

640

5029

S02CA02

ATC

flumetasone and antiinfectives; otic

1.5

7.5

232

1532

V01AA11

ATC

animals

9.9

7.5

E66.8

ICD-10 Finland

Other obesity

1.4

7.4

300

2091

N05AH04

ATC

quetiapine; oral

1.2

7.4

1102

9218

S01KA02

ATC

hypromellose; ophthalmic

2.4

7.4

245

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

4.2

7.4

L71.9

ICD-10 Finland

Rosacea, unspecified

1.9

7.4

108

579

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.7

7.4

178

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

7.4

395

2896

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.9

7.4

481

N06BA04

ATC

methylphenidate; oral

1.5

7.4

256

1732

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.2

7.4

2014

17767

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.4

7.3

413

3054

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.5

7.3

232

1538

A01AB10

ATC

natamycin; local oral

1.6

7.3

160

972

H29

ICPC

Ear symptom/complaint other

1.3

7.3

448

3358

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.1

7.3

3734

34405

E66.9

ICD-10 Finland

Obesity, unspecified

1.6

7.3

196

1253

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.4

7.2

300

2104

S21

ICPC

Skin texture symptom/complaint

1.3

7.2

617

4850

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

7.2

235

1569

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.0

7.2

430

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

7.2

280

1943

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.0

7.2

421

N02CC05

ATC

almotriptan; oral

1.4

7.2

278

1924

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

7.2

448

3369

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.0

7.2

435

K03.80

ICD-10 Finland

Irradiated enamel

1.4

7.1

279

1935

K04

ICPC

Palpitations/awareness of heart

1.5

7.1

234

1567

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.3

7.1

501

3835

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

0.3

7.1

551

L50.1

ICD-10 Finland

Idiopathic urticaria

2.5

7.1

211

S06

ICPC

Rash localized

1.5

7.1

267

1837

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

7.1

462

3499

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

2.4

7.1

231

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

7.1

1473

12709

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.4

7.0

292

2050

50708

ICD-8 Finland

Hay fever, Alia definita

3.8

7.0

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

7.0

282

1967

OAA65

SPAT

1.2

7.0

739

5958

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.3

7.0

260

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

7.0

653

5187

R03CC03

ATC

terbutaline; systemic

1.5

7.0

237

1598

M23.8

ICD-10 Finland

Other internal derangements of knee

1.5

7.0

201

1308

M01AC01

ATC

piroxicam; systemic, rectal

1.3

7.0

445

3359

K62.6

ICD-10 Finland

Ulcer of anus and rectum

2.6

7.0

190

4224

FHL

Endonasal anthrostomy

2.4

7.0

216

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

6.9

477

Z05

ICPC

Work problem

1.9

6.9

477

N02CC06

ATC

eletriptan; oral

1.5

6.9

242

1642

N89

ICPC

Migraine

1.4

6.9

307

2180

H10.8

ICD-10 Finland

Other conjunctivitis

2.3

6.9

246

N03AE01

ATC

clonazepam; systemic

1.5

6.9

246

1677

D10AF01

ATC

clindamycin; topical

1.4

6.9

326

2346

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

6.9

390

2890

J01CE02

ATC

phenoxymethylpenicillin; oral

1.1

6.9

5269

49738

UJD02

NOMESCO Finland

Gastroscopy

1.6

6.9

168

1050

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

2.9

6.9

139

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

1.6

6.8

160

991

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

6.8

281

1970

UKC02

NOMESCO Finland

Cystoscopy

1.3

6.8

439

3317

K90.0

ICD-10 Finland

Coeliac disease

1.6

6.8

163

1013

X48

ICD-10 Finland

Accidental poisoning by and exposure to pesticides

13.6

6.8

R50

ICPC

Respiratory, Medication/prescr/renewal

5.4

6.8

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.1

6.8

323

EG1CG

NOMESCO Finland

Extensive MRI examination of mandipular joint with high intensity magnet

3.0

6.8

119

4222

FHL

Endonasal etmoidectomy

3.3

6.8

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

6.8

139

829

S12

ICPC

Insect bite/sting

1.4

6.8

284

1999

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.6

6.8

167

1048

R52.9

ICD-10 Finland

Pain, unspecified

1.3

6.8

409

3064

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.4

6.8

313

2244

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.7

6.7

N06AX05

ATC

trazodone; oral

1.7

6.7

132

779

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

6.7

364

2678

L23

ICD-10 Finland

Allergic contact dermatitis

2.7

6.7

148

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

6.7

453

XG405

SPAT

3.0

6.7

120

I78.1

ICD-10 Finland

Naevus, non-neoplastic

1.8

6.7

112

630

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

6.7

235

1598

SPAT1360

SPAT

Extensive global examination

1.4

6.7

331

2402

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.8

6.7

113

636

N05AH02

ATC

clozapine; systemic

0.5

6.7

842

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

6.7

177

1132

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

1.7

6.6

117

670

L71.0

ICD-10 Finland

Perioral dermatitis

1.8

6.6

109

607

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.3

6.6

407

3052

WQ000

SPAT

22.3

6.6

R55

ICD-10 Finland

Syncope and collapse

1.3

6.6

386

2874

K80

ICPC

Cardiac arrhythmia NOS

1.4

6.6

261

1814

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

2.6

6.6

167

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

6.6

584

4610

N03AX11

ATC

topiramate; oral

1.6

6.6

179

1149

K07.62

ICD-10 Finland

Habitual dislocation of the jaw joint

2.3

6.6

230

F02

ICPC

Red eye

1.5

6.6

239

1639

X27

ICD-10 Finland

Contact with other specified venomous animals

6.3

6.6

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

6.6

524

4085

XG431

NOMESCO Finland

Oscillometric spirometry with exercise provocation

3.7

6.6

D11

ICPC

Diarrhoea

1.2

6.5

818

6722

WZB00

SPAT

1.3

6.5

562

4423

ACC51

NOMESCO Finland

Release of median nerve

1.4

6.5

299

2141

3DX05

NOMESCO Finland

12.1

6.5

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.4

6.5

205

J01.4

ICD-10 Finland

Acute pansinusitis

2.3

6.5

224

DAX08

NOMESCO Finland

Fitting of hearing aid

2.0

6.5

365

EMB20

NOMESCO Finland

Adenotonsillectomy

1.6

6.5

175

1124

J35.3

ICD-10 Finland

Hypertrophy of tonsils with hypertrophy of adenoids

1.7

6.5

129

764

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.0

6.5

379

M03AX01

ATC

botulinum toxin; parenteral

2.0

6.5

393

R49.0

ICD-10 Finland

Dysphonia

2.0

6.5

393

E66

ICD-10 Finland

Obesity

1.5

6.5

236

1619

WZA90

NOMESCO Finland

Other doctors statement

1.2

6.4

1613

14114

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

1.6

6.4

139

843

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

6.4

401

3018

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

6.4

199

1320

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

6.4

456

3499

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

1.6

6.4

149

923

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.7

6.4

120

700

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

6.4

203

1351

L29

ICPC

Musculoskeletal sympt/complt other

1.4

6.4

352

2598

V01AA03

ATC

house dust mites

69.2

6.4

Z04.3

ICD-10 Finland

Examination and observation following other accident

1.9

6.4

480

D84.18

ICD-10 Finland

Other specified defect in the complement system

5.2

6.4

R78

ICPC

Acute bronchitis/bronchiolitis

1.8

6.4

101

558

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.3

6.4

366

2720

H60

ICD-10 Finland

Otitis externa

1.4

6.4

270

1905

L01

ICD-10 Finland

Impetigo

1.7

6.4

114

656

G54.0

ICD-10 Finland

Brachial plexus disorders

1.6

6.3

143

877

K59.0

ICD-10 Finland

Constipation

1.5

6.3

217

1468

NGE10

NOMESCO Finland

Incision or suture of capsule of knee joint

2.8

6.3

130

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.3

6.3

426

3243

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

6.3

829

6846

L19

ICPC

Muscle symptom/complaint NOS

1.7

6.3

124

733

TCC30

NOMESCO Finland

Intubation of lacrimal canaliculus/duct

3.0

6.3

109

50709

ICD-8 Finland

Hay fever, Unspecified

3.4

6.3

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.6

6.3

149

927

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

2.5

6.3

178

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

6.3

329

2412

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

1.6

6.3

137

833

R06

ICD-10 Finland

Abnormalities of breathing

2.2

6.2

255

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

6.2

412

3129

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

6.2

289

2074

L10

ICPC

Elbow symptom/complaint

1.4

6.2

253

1773

N94.4

ICD-10 Finland

Primary dysmenorrhoea

1.5

6.2

192

1273

L04

ICPC

Chest symptom/complaint

1.4

6.2

290

2083

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

1.9

6.2

399

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.5

6.2

736

H81

ICPC

Excessive ear wax

1.3

6.2

501

3910

M15

ICD-10 Finland

Polyarthrosis

1.7

6.2

111

640

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

6.2

452

3481

H53.2

ICD-10 Finland

Diplopia

1.7

6.2

118

693

CS494

NOMESCO Finland

Other visual field testing

2.0

6.2

362

SPAT1281

SPAT

Other administrative function

1.3

6.2

458

3534

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

1.8

6.2

530

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

1.9

6.2

401

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.3

6.2

355

2643

M75.8

ICD-10 Finland

Other shoulder lesions

1.5

6.1

171

1105

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.4

6.1

236

1634

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.6

6.1

146

911

J05AH02

ATC

oseltamivir; oral

2.4

6.1

192

WX780

NOMESCO Finland

Remote monitoring CPAP

1.6

6.1

154

975

L57.0

ICD-10 Finland

Actinic keratosis

1.6

6.1

157

999

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.5

6.1

175

N02CC02

ATC

naratriptan; oral

1.8

6.1

103

584

S83.2

ICD-10 Finland

Tear of meniscus, current

1.4

6.1

321

2355

J31.2

ICD-10 Finland

Chronic pharyngitis

2.4

6.1

201

Z73.0

ICD-10 Finland

Burn-out

1.5

6.1

201

1352

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

6.2

6.1

C07AB02

ATC

metoprolol; systemic

1.3

6.1

526

4146

WX400

NOMESCO Finland

Inhalation anesthesy

1.4

6.1

281

2017

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

2.2

6.0

254

J01XX01

ATC

fosfomycin; systemic

1.8

6.0

469

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

221

24.59

309.93

1.1

1.0

u/ml

0.7

1.8

0.47

135

(3011841) English Walnut IgE Ab [Units/volume] in Serum

261

27.09

307.65

1.1

u/ml

5.9

6.1

0.02

205

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1064

1759

6.64

307.65

1.1

u/ml

7.5

3.3

4.48

597

686

(3005322) IgE [Units/volume] in Serum or Plasma

2072

5561

4.47

307.65

1.5

1.3

u/ml

483.2

205.6

8.46

1986

5117

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1595

2387

7.79

307.65

1.2

1.1

u/ml

2.0

1.9

0.01

969

937

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

254

37.43

307.65

1.0

u/ml

0.3

0.0

2.56

154

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

826

1427

6.19

307.65

1.1

1.0

u/ml

0.5

0.3

0.72

314

288

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

363

316

11.79

307.65

1.1

1.0

u/ml

11.7

7.5

0.73

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

231

26.92

307.65

1.1

1.0

u/ml

4.2

2.2

0.31

133

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

243

104

23.72

307.65

1.1

u/ml

2.6

2.5

0.02

191

(3023430) Cat dander IgE Ab [Units/volume] in Serum

978

1632

6.52

307.65

1.1

u/ml

7.2

5.4

1.28

588

674

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

404

174

23.98

307.65

1.2

1.1

u/ml

8.7

12.9

0.36

305

114

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1494

2025

8.52

307.65

1.2

1.1

u/ml

3.3

2.0

2.14

486

523

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1390

2046

7.74

307.65

1.1

u/ml

1.4

1.1

0.74

938

851

(3003888) Timothy IgE Ab [Units/volume] in Serum

1594

2097

8.89

307.65

1.2

1.1

u/ml

8.2

5.8

4.37

1203

1078

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

187

29.03

278.20

1.1

—

(4010399)

1159

3838

3.27

270.30

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

388

521

7.65

268.97

1.4

1.2

u/ml

1.0

0.9

0.11

152

169

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

195

22.13

262.55

1.1

1.0

u/ml

0.5

0.1

1.88

119

(3011897) Casein IgE Ab [Units/volume] in Serum

245

204

12.18

242.42

1.4

1.3

u/ml

25.2

1.0

1.91

(3012494) Peanut IgE Ab [Units/volume] in Serum

303

371

8.32

226.88

1.2

1.1

u/ml

14.4

10.8

0.14

237

226

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

157

23.93

218.20

1.0

u/ml

1.8

2.7

0.19

111

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

143

30.56

216.40

1.0

u/ml

1.1

3.2

0.31

110

(3013115) Eosinophils [#/volume] in Blood

5248

37521

1.89

187.18

5.9

6.7

e9/l

0.2

43.65

4691

33538

(3019420) Tryptase [Mass/volume] in Serum or Plasma

286

418

6.95

183.33

1.3

1.5

ug/l

5.2

6.5

1.51

259

368

(3000492) Spirometry study

1547

7238

2.34

179.55

1.5

1.4

—

(42870588) Differential panel, method unspecified - Blood

3648

23605

1.88

173.92

5.6

6.6

—

(3001604) Monocytes [#/volume] in Blood

5027

36122

1.83

169.20

5.7

6.4

e9/l

0.5

0.39

4441

31805

(3006315) Basophils [#/volume] in Blood

5034

36229

1.83

168.13

5.7

6.4

e9/l

0.0

5.17

4441

31849

(3019198) Lymphocytes [#/volume] in Blood

5192

37729

1.83

167.87

5.7

6.3

e9/l

2.0

0.08

4689

33881

(3018010) Neutrophils/100 leukocytes in Blood

4942

35446

1.82

166.11

5.5

6.2

54.5

55.5

8.32

4654

33549

(3019069) Monocytes/100 leukocytes in Blood

4820

34315

1.82

166.02

5.9

6.6

8.1

1.03

4540

32452

(3022096) Basophils/100 leukocytes in Blood

4668

32914

1.82

166.00

5.8

6.5

0.7

4.41

4367

30943

(3006504) Eosinophils/100 leukocytes in Blood

4792

34086

1.82

165.23

5.7

6.4

3.4

2.8

47.99

4495

32025

(3002030) Lymphocytes/100 leukocytes in Blood

4984

35971

1.81

162.73

5.8

6.3

30.6

30.5

0.43

4683

33949

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

115

20.56

150.46

1.0

u/ml

24.1

17.7

0.34

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

241

373

6.54

146.23

1.1

u/ml

13.0

10.1

0.46

100

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

118

15.97

137.07

1.1

1.0

u/ml

11.8

6.2

1.41

(3013650) Neutrophils [#/volume] in Blood by Automated count

5386

41345

1.70

126.95

7.2

9.1

e9/l

3.8

3.9

6.65

4740

36327

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1244

6279

2.11

115.90

3.8

3.3

31.5

31.9

0.51

881

4674

(3020874) Milk IgE Ab [Units/volume] in Serum

322

816

4.01

110.50

1.3

1.1

u/ml

9.8

1.2

1.92

190

274

(3013707) Erythrocyte sedimentation rate by Westergren method

6244

50979

1.66

105.65

4.2

3.7

mm/h

8.6

9.0

2.61

5816

47841

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

12.79

98.59

1.8

1.3

u/ml

15.2

5.1

0.73

(3014599) Egg white IgE Ab [Units/volume] in Serum

302

809

3.78

95.78

1.3

1.1

u/ml

12.4

4.3

0.92

183

228

(3015076) Soybean IgE Ab [Units/volume] in Serum

282

730

3.91

93.90

1.2

1.0

u/ml

1.3

1.0

0.15

112

(3016031) Almond IgE Ab [Units/volume] in Serum

11.11

93.03

1.0

1.1

u/ml

1.4

0.5

1.63

(3007164) IgA [Mass/volume] in Serum or Plasma

2685

18392

1.63

89.37

1.6

1.4

g/l

2.1

0.36

1607

11598

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3000

21289

1.59

85.30

1.4

u/ml

1.6

1.9

0.55

736

5817

(3019225) pH of Specimen

906

4803

1.96

71.74

3.5

—

(3013512) EKG study

2060

13931

1.60

69.18

2.9

2.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

11.82

68.56

1.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

10.88

65.88

1.1

u/ml

2.7

0.7

1.49

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8209

75016

1.77

61.23

11.5

10.3

mg/l

18.3

20.3

7.00

6398

56493

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2875

21540

1.47

57.88

1.9

1.7

pmol/l

100.5

98.4

1.52

1550

11793

(3048689) Calprotectin [Mass/mass] in Stool

1753

11842

1.57

57.73

2.8

2.7

ug/g

96.5

118.2

2.48

1348

9406

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

127

6.91

57.05

1.1

u/ml

0.0

0.25

(40768797) Stomach Pathology biopsy report

1267

7992

1.66

55.08

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

562

2785

2.06

53.34

1.5

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7529

68042

1.52

50.39

5.1

4.5

mu/l

2.0

1.9

0.15

7017

64312

(3037522) Nuclear Ab [Titer] in Serum

1588

10782

1.55

50.35

1.5

1.4

titre

494.4

562.4

0.66

288

2009

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6689

59118

1.44

49.69

4.4

4.0

pmol/l

14.4

0.15

6112

54803

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

196

611

3.22

49.24

2.7

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

522

2593

2.05

49.16

1.3

1.2

—

(44813793)

219

732

3.01

48.87

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3140

24508

1.41

48.35

1.9

1.7

—

(36660697) Celiac disease serology panel - Serum

1197

7762

1.60

45.94

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4509

37667

1.36

44.52

3.1

2.9

ug/l

85.5

80.5

0.29

4237

35732

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2071

15244

1.44

43.33

2.0

mg/l

0.8

1.0

1.33

1440

10960

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1093

7040

1.61

42.95

2.1

nmol/l

354.6

374.5

2.95

992

6530

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

192

643

3.00

42.73

1.1

iu/ml

5.9

7.2

0.29

164

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1689

12026

1.48

41.83

1.3

u/ml

7.6

9.2

0.61

634

5035

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1773

12748

1.47

41.76

1.4

1.3

iu/ml

21.6

25.7

0.70

456

3775

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

322

1413

2.30

41.44

1.2

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

482

2472

1.98

41.43

1.6

1.8

g/l

1.2

0.19

456

2369

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5644

49115

1.35

41.16

6.6

6.7

u/l

75.4

76.5

1.07

5264

46447

(3019550) Sodium [Moles/volume] in Serum or Plasma

7698

70616

1.48

40.68

10.7

10.5

mmol/l

139.6

0.09

7453

68629

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3499

28377

1.36

40.50

2.5

2.4

nmol/l

74.9

72.3

6.35

3213

26572

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

468

2399

1.98

40.27

1.6

1.9

g/l

0.2

0.36

440

2291

(3023103) Potassium [Moles/volume] in Serum or Plasma

7713

70830

1.48

40.04

10.8

10.5

mmol/l

3.9

9.95

7433

68627

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

852

5266

1.66

39.33

2.4

2.3

au/ml

20.3

21.6

0.15

387

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

798

4872

1.68

38.58

1.3

au/ml

45.4

40.2

0.23

180

(3047007) Chlamydophila sp Ab [Presence] in Serum

318

1435

2.24

38.29

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

3305

26783

1.34

37.63

1.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

176

610

2.89

36.88

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3140

25309

1.35

36.86

5.1

6.2

mmol/l

1.2

3.04

2816

23293

(3004616) Nuclear Ab [Presence] in Serum

205

780

2.64

35.96

1.4

1.3

—

(40758558) Short blood count panel - Blood

2303

17747

1.38

35.87

5.2

7.2

—

(3000494) Fungus identified in Specimen by Culture

1113

7508

1.53

35.29

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

14.44

35.20

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

192

718

2.68

34.87

1.4

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

115

319

3.60

34.79

1.2

g/l

0.3

0.09

259

(3028026) IgM [Mass/volume] in Serum or Plasma

727

4448

1.67

34.75

1.8

g/l

1.3

0.01

659

4150

(3019309) Folate [Moles/volume] in Red Blood Cells

1175

8047

1.51

34.65

1.7

nmol/l

1083.6

1165.6

2.44

857

6318

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

108

288

3.74

34.62

1.2

111.6

108.4

0.62

100

259

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5945

52735

1.33

34.56

3.1

2.9

u/l

35.8

36.7

0.53

5617

50450

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2414

18850

1.36

34.32

2.8

2.7

ng/l

19.0

51.3

1.75

1111

8710

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

192

724

2.66

34.30

1.4

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1167

8005

1.51

34.12

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

190

715

2.66

34.08

1.4

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

517

2891

1.82

34.01

1.6

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7355

67472

1.39

33.66

4.3

3.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7114

64938

1.37

33.32

9.1

8.7

ml/min/173m2

94.9

95.0

0.08

5698

51956

(3005988) Vibrio sp identified in Specimen by Organism specific culture

189

718

2.64

33.28

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

189

718

2.64

33.28

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

193

741

2.61

33.27

1.4

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5540

48845

1.31

32.56

4.1

3.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2087

16045

1.37

32.42

2.4

2.2

mg/l

2.6

2.7

1.57

1775

13890

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

141

4.94

32.27

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

884

5795

1.56

31.72

2.5

2.7

g/l

10.2

10.4

0.78

806

5353

(3022145) Colonoscopy Study observation

1010

6857

1.51

30.83

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

107

307

3.48

30.81

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

334

1679

2.00

30.37

1.2

1.1

au/ml

14.7

10.7

0.28

114

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2018

15605

1.36

29.83

2.1

u/l

174.4

227.6

1.43

1892

14844

(3003327) Ova and parasites identified in Stool by Light microscopy

554

3296

1.71

29.32

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

857

5676

1.54

29.28

1.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3366

28053

1.30

29.14

5.7

6.6

mmol/l

1.2

4.36

2855

24007

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8270

77955

1.49

28.43

9.0

8.4

u/l

26.8

26.7

0.21

8008

75741

(3024139) IgG subclass 3 [Mass/volume] in Serum

201

850

2.37

28.25

1.4

g/l

0.3

0.4

0.80

171

596

(3027135) IgG subclass 1 [Mass/volume] in Serum

201

850

2.37

28.25

1.4

1.3

g/l

6.5

0.04

170

599

(3028192) IgG subclass 2 [Mass/volume] in Serum

201

851

2.37

28.18

1.4

1.3

g/l

3.0

2.9

0.64

171

601

(3021589) Normoblasts [#/volume] in Blood

3851

32768

1.28

27.96

7.9

8.6

e9/l

0.0

1.25

3105

26862

(3009445) Proteinase 3 Ab [Units/volume] in Serum

446

2530

1.78

27.93

1.9

1.6

u/ml

15.0

9.4

0.31

102

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

11.51

27.90

1.1

—

(4062490)

199

851

2.34

27.28

1.5

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

919

6295

1.49

26.69

4.0

5.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

320

1660

1.94

26.60

1.5

iu/ml

26.0

11.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5217

46236

1.27

26.47

4.1

3.8

e6/l

2597.5

1331.2

0.60

561

(3007461) Platelets [#/volume] in Blood

8925

85911

1.95

25.94

16.8

15.2

e9/l

265.2

262.1

5.17

8755

83902

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

161

640

2.52

25.92

1.5

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

381

2110

1.82

25.85

1.3

u/ml

66.6

33.0

0.86

145

(3013139) Helicobacter pylori Ag [Presence] in Stool

718

4704

1.55

25.66

1.2

—

(3035941) MCH [Entitic mass]

8931

86008

1.96

25.61

16.7

15.1

29.9

0.13

8852

85066

(3000963) Hemoglobin [Mass/volume] in Blood

8935

86067

1.97

25.49

16.8

15.3

g/l

136.8

136.4

2.35

8857

85126

(3017732) Neutrophils [#/volume] in Blood

752

4993

1.53

25.29

2.0

2.3

e9/l

4.3

4.2

0.35

568

4204

(3026361) Erythrocytes [#/volume] in Blood

8931

86028

1.95

25.28

16.7

15.2

e12/l

4.6

2.04

8739

83896

(3024731) MCV [Entitic volume]

8929

86006

1.95

25.22

16.7

15.1

89.5

0.00

8849

85068

(3010813) Leukocytes [#/volume] in Blood

8932

86062

1.94

24.93

16.8

15.2

e9/l

6.7

0.28

8739

83899

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

351

1925

1.84

24.59

1.3

u/ml

15.8

12.4

0.19

304

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7018

64779

1.30

24.46

3.7

3.3

mmol/l

5.6

2.31

6466

60739

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

371

2077

1.80

24.29

1.8

1.7

titre

465.5

374.7

0.14

(3024980) IgG subclass 4 [Mass/volume] in Serum

265

1334

1.99

24.05

1.7

1.6

g/l

0.8

0.7

0.86

229

1025

(40761511) CBC panel - Blood by Automated count

8358

79330

1.47

23.77

10.4

9.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1516

11571

1.35

23.71

1.5

1.4

nmol/l

20.1

20.3

0.26

1309

10308

(40768443) Skin Pathology biopsy report

423

2481

1.72

23.57

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6374

58255

1.27

23.18

4.5

4.1

mmol/mol

37.4

37.6

0.71

5935

55206

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

343

1904

1.81

23.11

1.3

u/ml

11.8

8.2

0.14

192

(3009542) Hematocrit [Volume Fraction] of Blood

7918

74515

1.37

23.04

11.6

11.2

40.7

40.4

4.23

6587

61929

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

262

1337

1.97

22.89

1.5

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

124

463

2.67

22.73

1.3

1.2

u/ml

30.5

46.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

454

2751

1.67

22.40

1.8

2.0

u/l

39.2

39.5

0.14

408

2548

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

121

456

2.65

21.80

1.3

1.2

u/ml

120.9

38.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

478

2968

1.63

21.42

3.7

5.4

mmol/l

24.4

0.08

452

2863

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1979

15921

1.29

21.01

2.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

312

1736

1.81

20.89

1.7

2.0

mg/l

10.5

10.4

0.09

282

1649

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

104

371

2.79

20.85

1.8

2.2

ug/l

208.1

103.0

0.23

345

(3020961) Endomysium IgA Ab [Titer] in Serum

739

5099

1.47

20.52

1.2

titre

102.0

213.3

1.38

161

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

115

439

2.61

20.23

1.3

1.2

u/ml

18.4

16.8

0.05

(3022313) Gas panel - Capillary blood

492

3122

1.59

20.15

3.6

5.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3593

31103

1.23

20.15

4.8

5.6

umol/l

11.0

10.8

0.28

3339

29213

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1301

9927

1.35

20.09

2.7

3.0

ng/l

709.0

739.2

0.08

973

7991

(4015189)

5.23

19.32

3.2

2.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

441

2766

1.61

18.97

1.1

u/ml

3.6

5.3

0.76

417

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

273

1504

1.82

18.91

1.2

1.3

u/ml

1.6

3.5

0.96

109

(3009343) pH of Capillary blood

607

4107

1.49

18.56

3.5

5.1

7.4

0.01

451

(3023419) Bacteria identified in Sputum by Culture

119

482

2.46

18.54

2.6

3.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

202

1018

1.98

18.37

1.5

1.3

titre

103.3

183.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

609

4142

1.49

18.15

3.6

5.1

kpa

5.1

0.78

581

3913

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

592

4014

1.49

17.91

3.6

5.1

mmol/l

0.9

1.3

2.27

416

2861

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

167

793

2.10

17.88

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

7.51

17.57

1.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2297

19195

1.25

17.20

2.4

3.0

mmol/l

2.4

0.54

1966

17308

(3026493) Urate [Moles/volume] in Serum or Plasma

1770

14365

1.27

17.04

2.2

2.4

umol/l

2780.3

2857.2

0.04

1549

12936

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

379

2367

1.61

16.62

1.7

2.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2309

19378

1.24

16.50

2.4

2.5

u/l

54.3

56.8

1.64

2107

18016

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

128

566

2.25

16.41

1.8

2.0

mg/l

16.9

26.3

2.15

160

(40760892) CBC W Ordered Manual Differential panel - Blood

2148

17902

1.24

16.33

4.0

4.2

—

(3044640) Blood type and Crossmatch panel - Blood

2473

20943

1.23

16.17

2.1

2.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1100

8450

1.33

15.99

1.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1185

9242

1.31

15.43

2.3

2.4

umol/l

14.8

14.4

0.86

1100

8643

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

945

7156

1.34

15.12

1.3

1.2

iu/ml

118.8

148.3

1.56

339

2720

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

394

2.45

15.11

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1751

14441

1.25

14.39

1.6

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

135

646

2.08

14.26

1.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

457

3082

1.49

14.22

1.3

u/ml

0.4

1.0

1.55

246

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1075

8369

1.31

14.12

2.2

2.4

g/l

2.5

0.86

999

7791

(3024561) Albumin [Mass/volume] in Serum or Plasma

2819

24442

1.20

14.11

4.4

4.9

g/l

37.4

37.1

2.64

2600

22905

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

360

2312

1.56

14.06

2.0

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4103

36823

1.18

13.85

4.1

4.5

mmol/l

6.3

0.19

3752

33318

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7241

68357

1.23

13.71

3.9

3.6

mmol/l

2.9

0.88

6764

64675

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7158

67519

1.22

13.53

3.7

3.4

mmol/l

1.5

1.39

6703

64168

(3023368) Bacteria identified in Blood by Culture

1621

13398

1.24

12.90

3.5

4.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7194

67985

1.22

12.85

3.7

3.4

mmol/l

4.7

0.82

6755

64759

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

22.30

12.80

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

300

1898

1.58

12.54

1.4

u/l

18.6

19.8

0.27

232

1592

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

323

2083

1.55

12.43

1.9

1.8

—

(3018001) Oat IgE Ab [Units/volume] in Serum

3.95

12.39

1.1

1.0

u/ml

0.8

0.1

1.29

(42529406) Shigella sp [Presence] in Stool by Culture

342

2240

1.53

12.27

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

340

2225

1.53

12.24

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

257

1579

1.63

12.14

1.1

u/ml

3.6

3.1

0.18

118

785

(3000570) Elastase.pancreatic [Mass/mass] in Stool

261

1612

1.62

12.08

1.4

ug/g

313.4

312.9

0.01

118

830

(3048929) Epstein Barr virus Ab [Presence] in Serum

631

4656

1.37

11.92

1.3

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6891

64989

1.20

11.91

3.4

3.1

mmol/l

1.3

1.2

0.58

6436

61711

(1002224) Polysomnography panel

490

3469

1.42

11.84

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

971

7633

1.29

11.77

2.3

2.5

24.1

24.0

0.11

880

6680

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

210

1235

1.70

11.76

2.5

2.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

709

5338

1.34

11.74

2.8

3.4

pmol/l

4.7

4.6

0.63

620

4840

(3004588) Protein electrophoresis panel - Serum or Plasma

358

2405

1.49

11.41

2.3

2.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

333

2211

1.51

11.23

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2285

19766

1.19

11.21

2.3

2.2

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

6.74

10.86

1.0

u/ml

0.3

0.1

0.72

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

195

1150

1.69

10.84

2.7

2.1

g/l

0.7

0.6

0.23

166

1051

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

223

2.63

10.79

1.1

—

(3032080) INR in Blood by Coagulation assay

2268

19666

1.19

10.75

5.4

5.8

inr

1.1

0.69

673

6582

(3025941) Bacteria identified in Stool by Culture

637

4785

1.34

10.72

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

268

1723

1.56

10.51

1.2

1.3

u/ml

38.5

40.5

0.05

160

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

181

1059

1.70

10.38

2.4

2.0

g/l

38.8

0.03

155

952

(3017446) Testosterone [Moles/volume] in Serum or Plasma

676

5147

1.32

10.36

2.4

2.2

nmol/l

12.0

11.6

0.67

604

4603

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

234

2.55

10.32

1.5

1.3

u/ml

29.6

17.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

457

3280

1.40

10.24

2.4

2.5

g/l

67.3

67.1

0.26

410

3077

(3024891) Influenza virus A+B Ag [Presence] in Specimen

355

2436

1.46

10.20

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

1896

16252

1.19

10.16

3.6

4.1

96.8

94.7

3.81

1839

15821

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2474

21701

1.18

10.11

2.5

2.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

186

2.72

10.02

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

168

975

1.72

9.94

1.1

g/l

1.4

1.5

1.01

143

894

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

385

2697

1.43

9.91

1.5

—

(4146454)

395

2.14

9.83

3.4

2.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

363

2.19

9.82

4.1

4.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

528

3908

1.36

9.80

1.1

u/ml

37.6

11.6

0.30

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

209

1292

1.61

9.72

2.3

2.0

g/l

3.0

3.1

0.59

159

1037

(3042936) Bacteria identified in Isolate by Culture

1011

8189

1.25

9.49

2.0

1.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

265

1744

1.52

9.39

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

206

2.55

9.22

1.7

1.2

titre

26.0

63.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

136

2.92

8.97

1.2

1.3

—

(36304419) Bacteria [Presence] in Urine

1976

17170

1.18

8.88

2.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

287

1948

1.47

8.77

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

162

968

1.67

8.67

2.6

2.0

g/l

0.0

0.00

149

918

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

163

976

1.66

8.65

2.6

2.0

g/l

0.0

0.45

149

920

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

5.26

8.54

1.1

1.0

u/ml

0.8

0.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

120

2.98

8.38

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

200

1270

1.57

8.37

1.2

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

210

1349

1.55

8.36

2.3

2.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

200

1271

1.57

8.35

1.2

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

210

1350

1.55

8.33

2.3

2.0

g/l

6.9

7.2

1.99

165

1061

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

196

1241

1.57

8.31

2.4

2.0

g/l

10.0

10.4

0.67

160

1087

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

130

741

1.75

8.28

2.3

3.0

e6/l

547.1

536.3

0.09

108

587

(3002523) Influenza virus A Ag [Presence] in Specimen

284

1951

1.45

8.19

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

149

2.73

8.18

1.3

1.4

—

(3008898) HLA-B27 [Presence]

504

3810

1.33

8.16

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

209

1349

1.55

8.15

2.3

2.0

g/l

3.8

0.05

158

1000

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

494

3727

1.33

8.11

1.6

mg/l

3.3

3.7

0.59

343

2490

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

350

2506

1.40

8.03

1.9

1.7

nmol/l

39.3

39.4

0.03

342

2457

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

172

1065

1.61

8.03

2.5

2.0

g/l

0.0

0.08

157

1006

(3027945) Reticulocytes/100 erythrocytes in Blood

681

5378

1.27

7.94

3.1

3.5

1.6

1.7

1.61

579

4874

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

5.50

7.90

1.0

u/ml

0.8

0.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

516

3938

1.31

7.82

1.7

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

125

2.86

7.82

1.6

1.7

mg/l

2.3

1.9

0.18

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

125

2.86

7.82

1.6

1.7

mg/l

4.0

3.9

0.02

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

125

2.86

7.82

1.6

1.7

mg/l

3.2

2.7

0.18

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

125

2.86

7.82

1.6

1.7

mg/l

1.3

1.6

0.30

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

125

2.86

7.82

1.6

1.7

mg/l

1.1

1.3

0.28

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

125

2.86

7.82

1.6

1.7

mg/l

1.1

0.01

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

125

2.86

7.82

1.6

1.7

mg/l

2.2

1.8

0.15

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

125

2.86

7.82

1.6

1.7

mg/l

1.3

1.2

0.03

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

125

2.86

7.82

1.6

1.7

mg/l

3.6

3.0

0.21

(3018095) Leukocytes [#/volume] in Urine

2602

23277

1.15

7.79

3.4

3.5

e6/l

46.7

67.9

1.41

1688

15367

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

127

733

1.72

7.77

2.3

3.0

e9/l

0.2

0.21

108

589

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

6.13

7.60

1.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

128

2.79

7.50

1.6

1.8

mg/l

1.0

1.4

0.29

(3013005) Retinol [Moles/volume] in Serum or Plasma

537

1.83

7.49

2.3

2.4

umol/l

1.9

1.8

1.47

514

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

686

5464

1.26

7.45

2.9

2.7

g/l

0.2

2.19

638

5143

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.55

7.43

2.7

1.6

umol/l

38.8

43.5

0.23

(3030467) Casts [#/volume] in Urine by Automated count

1944

17090

1.16

7.36

3.0

2.9

e6/l

0.2

0.3

4.09

1404

12588

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

652

5190

1.26

7.13

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

522

4044

1.29

7.10

1.5

u/l

8.2

8.6

0.36

419

3235

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

369

2722

1.36

7.09

1.6

iu/ml

0.1

6.4

0.52

538

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

4.66

7.04

1.0

u/ml

0.5

0.1

—

(3011412) CD3 cells [#/volume] in Blood

149

923

1.61

7.00

2.3

2.9

e9/l

1.5

1.3

1.43

557

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

349

4605

0.74

6.97

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

379

4933

0.75

6.89

1.5

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1314

11255

1.18

6.88

1.6

pmol/l

16123614.4

33825160.6

0.97

1104

9768

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

292

3949

0.72

6.84

1.4

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

175

1133

1.54

6.81

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

640

5113

1.26

6.79

3.8

4.5

0.1

0.67

138

1208

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1061

8929

1.20

6.79

2.1

2.6

mmol/l

2.4

1.62

905

7770

(3007700) Barley IgE Ab [Units/volume] in Serum

3.52

6.73

1.1

u/ml

0.9

0.01

(3009508) Creatinine [Moles/volume] in Urine

1972

17460

1.15

6.69

3.3

3.4

mmol/l

8.4

8.3

0.11

1675

15301

(4094501)

194

1290

1.50

6.67

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

112

657

1.70

6.54

1.1

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

283

2.07

6.43

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

335

2475

1.35

6.41

1.2

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

215

1472

1.46

6.40

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

111

656

1.68

6.32

1.1

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

3.35

6.29

1.1

u/ml

1.1

0.6

0.27

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

111

657

1.68

6.28

1.1

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1050

8894

1.19

6.25

3.3

4.5

mmol/l

0.8

1.01

964

8389

(3042631) Mycobacterium sp identified in Specimen

453

1.82

6.23

2.9

2.7

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

6.60

6.22

1.0

—

(3017181) Myelocytes/100 leukocytes in Blood

658

5336

1.24

6.13

3.8

4.4

0.7

0.8

0.33

148

1304

(3002179) Metamyelocytes/100 leukocytes in Blood

613

4933

1.25

6.12

3.3

4.1

0.4

0.5

0.72

112

972

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

109

649

1.67

6.05

1.1

1.2

—

(3025159) Blasts/100 leukocytes in Blood

610

4914

1.24

6.04

3.9

4.5

0.0

0.2

1.03

124

1042

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

109

651

1.66

5.98

1.1

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

238

1690

1.40

5.84

2.2

2.5

ug/l

448.7

447.0

0.00

201

1528

(40759836) Histone Ab [Presence] in Serum by Immunoblot

108

648

1.66

5.84

1.1

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

473

3716

1.27

5.82

2.5

3.2

e9/l

68.9

71.0

0.69

340

2668

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1781

15799

1.14

5.79

1.6

mmol/l

1.4

0.20

1568

13842

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

210

2.17

5.73

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

210

2.17

5.73

1.2

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

224

1582

1.41

5.68

2.2

1.8

pmol/l

193.9

192.7

0.05

217

1508

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

110

671

1.63

5.59

2.1

3.0

e6/l

769.0

838.6

0.39

229

(3035933) Granulocytes/100 leukocytes in Blood

398

1.82

5.54

1.4

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

133

2.46

5.47

4.2

4.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

202

2.16

5.43

1.0

1.2

—

(3027020) Pear IgE Ab [Units/volume] in Serum

15.85

5.37

1.0

u/ml

0.5

0.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

461

1.74

5.35

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

197

2.16

5.34

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

104

634

1.63

5.32

3.1

3.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

883

7474

1.19

5.30

2.4

3.2

umol/l

5.8

6.6

0.92

759

6351

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

216

1537

1.40

5.28

3.0

3.8

55.2

56.0

0.49

216

1537

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

324

2457

1.32

5.26

2.3

2.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

669

5528

1.21

5.22

1.6

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

312

2356

1.32

5.22

1.2

1.4

u/ml

247.1

234.1

0.36

181

1442

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

294

2202

1.33

5.21

1.5

—

(3012516) Albumin [Mass/volume] in Urine

1439

12671

1.15

5.18

3.5

3.4

mg/l

549.9

405.5

0.43

859

8277

(3035637) Corticotropin [Mass/volume] in Plasma

158

1066

1.47

5.16

1.4

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

293

2197

1.33

5.15

1.3

—

(4024509)

497

1.70

5.11

1.6

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

330

1.86

5.11

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2605

23808

1.12

5.10

2.9

3.2

u/l

30.2

31.4

0.61

2473

22754

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

732

6115

1.20

5.10

2.2

2.4

u/l

35.2

44.7

0.59

620

5289

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

679

5636

1.21

5.06

3.4

4.6

u/l

227.0

238.8

1.43

632

5361

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

255

1.98

5.05

1.2

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

992

8521

1.17

4.99

3.7

3.4

ug/l

1.7

0.10

874

7783

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1167

10154

1.16

4.96

2.6

e6/l

0.8

1.0

2.12

634

5483

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

423

3353

1.26

4.88

1.5

—

(3003129) Base excess in Capillary blood by calculation

2.70

4.82

1.0

1.4

mmol/l

-0.5

0.6

1.23

(3026782) Osmolality of Urine

1349

11884

1.14

4.81

2.5

2.6

mosm/kgh2o

540.1

554.5

1.32

1117

10155

(3034770) Mitochondria Ab [Titer] in Serum

278

2093

1.32

4.78

1.3

1.4

titre

2176.0

1022.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

261

1.94

4.75

1.2

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

105

664

1.57

4.67

1.2

1.3

titre

373.1

206.8

0.55

141

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

365

1.77

4.55

1.2

100.6

94.6

0.68

158

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

142

965

1.46

4.52

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

159

1105

1.43

4.50

1.3

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

2066

18754

1.12

4.50

3.0

e6/l

48.9

81.1

1.00

1535

14083

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

4.36

4.49

1.0

u/ml

0.1

0.0

0.94

(3000850) Epithelial cells [#/volume] in Urine

1441

12819

1.13

4.42

2.4

2.5

e6/l

6.8

7.2

0.43

1230

11190

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

376

1.74

4.41

1.1

99.0

94.4

0.89

160

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1376

12207

1.14

4.40

1.6

1.7

1.3

1.4

0.74

1224

11032

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

101

646

1.55

4.31

1.3

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

132

894

1.47

4.30

1.7

1.6

—

(3014271) Vancomycin [Susceptibility]

124

2.32

4.29

2.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

387

1.72

4.28

1.2

121.6

107.1

2.40

348

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

111

727

1.52

4.26

2.2

2.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

670

5648

1.19

4.25

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

682

5762

1.18

4.22

1.4

—

(3006462) Nitrate [Presence] in Urine

302

1.81

4.18

3.1

2.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1104

9686

1.15

4.18

2.6

2.7

e6/l

3.5

3.6

0.08

569

5019

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

114

2.35

4.12

1.1

1.2

u/ml

22.8

28.7

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

4.03

4.09

1.0

1.1

u/ml

0.0

0.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

131

898

1.45

4.04

2.4

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

643

1.53

3.98

1.3

1.2

—

(3018418) pH of Serum or Plasma

1780

16129

1.11

3.96

3.4

3.9

7.4

1.52

340

3147

(3032057) Clostridioides difficile [Presence] in Stool

2.48

3.94

1.6

2.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.43

3.94

1.8

1.6

ug/l

0.4

0.5

0.47

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

535

1.58

3.93

1.6

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

237

1.88

3.92

2.5

3.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

760

0.54

3.88

14.1

14.3

nmol/l

834.5

813.5

0.10

734

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

439

1.63

3.80

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

582

4899

1.19

3.79

2.6

2.4

ug/l

0.6

0.32

306

2542

(3002256) Pathology report gross observation

915

7984

1.15

3.76

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

467

3856

1.21

3.75

3.7

4.5

ng/l

68.2

75.2

1.40

416

3504

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

277

1.79

3.73

1.2

1.1

u/ml

63.4

50.1

0.72

271

(3000060) B lymphocytes [#/volume] in Blood

459

1.60

3.66

2.2

3.0

e6/l

277.6

259.3

0.17

275

(3037756) Immunofixation for Serum or Plasma

616

1.52

3.66

1.8

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

3777

35591

1.08

3.57

3.1

3.2

estimate

0.0

0.20

681

6931

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

189

1.94

3.55

1.4

1.5

ug/l

9.8

8.7

0.76

189

(3029075) Extractable nuclear Ab panel - Serum

260

1.79

3.54

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

246

1.81

3.52

1.4

1.5

u/l

10.3

12.4

1.52

240

(3007566) Smooth muscle Ab [Titer] in Serum

274

2154

1.27

3.50

1.3

1.4

titre

110.3

118.5

0.09

225

(4211845)

335

1.69

3.49

3.0

2.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1463

13207

1.11

3.47

4.1

4.2

mg/mmol

10.9

11.7

0.13

871

8759

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

113

778

1.44

3.46

2.2

2.6

10.9

11.6

0.44

486

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

241

1.81

3.43

1.2

1.1

74.7

74.8

0.00

(3017143) Hepatitis C virus Ab [Presence] in Serum

1494

13525

1.11

3.36

1.6

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

3746

35349

1.08

3.36

4.3

estimate

0.0

2.33

698

7117

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

184

1381

1.32

3.36

1.3

u/ml

4.3

4.4

0.04

621

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

317

2551

1.24

3.32

2.7

3.4

159.1

167.0

1.15

300

2427

(3028707) Methadone [Presence] in Urine by Screen method

390

3207

1.21

3.31

2.8

2.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

740

6429

1.15

3.26

1.4

iu/l

18.6

22.5

3.37

635

5412

(3044927) Protein electrophoresis panel - Urine

290

1.71

3.24

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

129

924

1.39

3.20

1.6

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

270

1.73

3.16

1.8

2.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1068

9538

1.12

3.08

3.1

3.0

ng/l

204.5

511.6

5.12

562

5392

(3021788) Differential panel - Synovial fluid

125

901

1.38

3.01

1.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.30

3.00

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.77

2.99

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

173

2214

0.77

2.97

1.7

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

756

6629

1.14

2.94

3.0

3.1

21.1

21.2

0.04

234

2284

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

269

1.70

2.92

1.8

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

269

1.70

2.92

1.8

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

269

1.70

2.92

1.8

2.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.72

2.92

1.0

1.5

umol/24h

0.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

552

4741

1.16

2.88

1.4

1.3

miu/ml

233.7

227.4

0.15

271

2333

(3019174) dRVVT (LA screen)

2.25

2.86

1.3

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

242

1.72

2.83

1.2

1.1

82.0

87.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

203

0.34

2.78

5.4

7.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

458

3890

1.17

2.76

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

641

1.42

2.73

1.1

mg/l

290.1

287.7

0.12

593

(3034860) Kappa light chains.free [Mass/volume] in Serum

126

930

1.35

2.66

3.5

3.2

mg/l

37.4

51.7

0.89

106

746

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

126

931

1.34

2.64

3.5

3.2

mg/l

24.0

46.0

1.76

106

749

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

122

897

1.35

2.64

1.3

umol/l

5.1

6.0

2.17

115

837

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

517

4455

1.16

2.61

7.0

9.4

mmol/l

24.7

0.02

512

4434

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

181

1410

1.28

2.59

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

136

1020

1.32

2.58

1.4

2.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

444

1.50

2.58

2.6

3.4

ug/l

1.0

1.5

0.84

421

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.31

2.58

1.1

1.0

—

(3035350) Ketones [Presence] in Urine by Test strip

3711

35250

1.07

2.58

3.1

estimate

0.0

1.08

677

6845

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

197

1.76

2.58

2.4

2.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

282

2311

1.21

2.56

2.1

2.6

umol/l

4.4

6.1

4.37

207

1724

(3036489) Thrombin time

359

3010

1.19

2.55

2.3

3.0

21.4

21.2

0.23

305

2557

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

110

801

1.36

2.54

1.4

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

264

2152

1.22

2.53

1.3

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

134

1.92

2.52

1.2

1.3

pmol/l

241.3

290.4

0.59

(46235355) HIV 1 and 2 tests - Meaningful Use set

2882

27164

1.07

2.49

2.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

122

908

1.33

2.46

3.5

3.1

ratio

1.3

1.9

0.58

100

(3012501) Base excess in Blood by calculation

165

1281

1.28

2.45

2.9

4.1

mmol/l

2.3

2.1

0.49

800

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

356

4123

0.85

2.42

1.9

2.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

940

8456

1.11

2.41

2.2

2.8

29.4

29.6

0.54

899

8197

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

574

1.42

2.41

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

247

1.65

2.39

1.5

1.6

—

(3016330) Potassium [Moles/time] in 24 hour Urine

109

2.00

2.39

1.1

1.4

—

99.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

616

5411

1.14

2.38

1.7

1.6

mu/l

314.2

318.0

0.09

556

4857

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

288

2385

1.20

2.37

9.0

10.9

mmol/l

24.3

24.1

0.57

271

2265

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

568

1.41

2.36

1.0

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1730

16026

1.08

2.36

3.1

3.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

470

1.46

2.35

2.4

3.0

58.2

55.1

0.57

304

(1616796) Gas panel - Central venous blood

161

1254

1.28

2.34

3.1

3.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

381

3237

1.17

2.34

1.9

2.1

ug/l

7.0

6.8

0.05

319

2860

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

264

1.61

2.34

1.1

u/l

14.6

17.9

0.36

209

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

145

1115

1.29

2.33

2.6

3.0

nmol/l

24.4

22.7

0.90

139

1080

(3010421) pH of Blood

189

1504

1.25

2.30

2.9

4.0

7.4

0.74

163

1262

(3001019) Free T4 and TSH panel - Serum or Plasma

669

5921

1.13

2.30

1.7

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

132

1683

0.77

2.29

4.5

5.5

0.9

0.17

121

1572

(3051593) INR in Capillary blood by Coagulation assay

118

1.93

2.28

1.3

9.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

183

1455

1.25

2.26

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

133

1.86

2.23

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

134

1697

0.78

2.22

4.6

5.4

1.6

1.8

1.38

122

1584

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

125

950

1.31

2.21

1.2

1.1

94.3

95.0

0.10

115

901

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

305

2558

1.19

2.21

3.1

3.8

g/l

3.3

3.4

0.40

291

2422

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

104

771

1.34

2.19

1.4

1.3

nmol/l

20.7

33.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

102

754

1.34

2.19

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

357

3040

1.17

2.16

2.6

2.9

ng/l

93.0

123.9

1.70

305

2680

(3024869) Neuronal Ab [Presence] in Serum

2.17

2.15

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

463

1.43

2.15

2.6

2.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

177

1412

1.24

2.14

1.6

1.8

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

259

2148

1.20

2.14

1.3

1.5

u/ml

20.6

22.5

—

(3052851) Hemolysis interference index of Serum or Plasma

230

1887

1.21

2.13

2.6

2.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

463

4025

1.15

2.12

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

399

1.47

2.12

2.6

2.3

mg/l

9.9

9.5

0.21

329

(3016038) Potassium [Moles/volume] in Urine

343

1.50

2.11

1.7

1.9

mmol/l

32.1

35.6

0.44

323

(3048879) Bone marrow aspiration report

2.05

2.11

1.8

2.8

—

(21494815) CD4 cells/100 lymphocytes in Specimen

111

837

1.32

2.10

2.0

2.8

43.3

45.2

0.17

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

624

1.37

2.10

1.3

1.4

pmol/l

45.7

106.5

0.63

189

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

265

1.57

2.08

1.1

u/l

78.3

75.8

0.11

219

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

401

1.46

2.07

1.5

1.7

nmol/l

2.1

2.8

0.28

323

(3003458) Phosphate [Moles/volume] in Serum or Plasma

841

7588

1.11

2.07

5.4

7.0

mmol/l

1.1

0.43

775

7155

(3001556) Androgen free Index in Serum or Plasma

204

1.65

2.05

1.4

1.2

—

(3028300) Cannabinoids [Presence] in Urine

834

7525

1.11

2.05

2.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.03

2.05

1.3

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

568

1.38

2.04

1.2

u/l

75.6

72.2

0.05

402

(3002385) Erythrocyte distribution width [Ratio]

6807

66186

1.07

2.04

12.9

12.8

13.3

13.4

1.52

6712

64850

(3027008) Opiates [Presence] in Urine

832

7509

1.11

2.04

2.0

2.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

106

799

1.32

2.02

1.2

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

420

1.44

2.01

1.8

1.6

u/l

4.7

6.5

2.55

359

(3000475) Leukocytes [#/volume] in Synovial fluid

142

1113

1.27

2.01

1.6

1.7

e6/l

10855.4

11500.9

0.05

101

817

(3006184) Hemoglobin [Mass/volume] in Capillary blood

160

1273

1.25

2.00

2.0

2.2

g/l

132.9

133.9

0.21

988

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

729

6542

1.11

2.00

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

214

1.62

1.98

2.0

2.2

—

(3011985) Renin [Units/volume] in Plasma

112

854

1.30

1.97

1.7

mu/l

77.6

64.5

0.25

784

(3044889) 12 lead EKG panel

4387

42130

1.06

1.97

2.9

2.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

725

1.33

1.97

1.6

1.7

—

(4306422)

174

1402

1.23

1.95

1.3

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

625

1.35

1.93

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

4.50

1.92

1.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

697

1.32

1.87

3.6

3.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

157

0.38

1.87

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

955

0.73

1.86

1.9

—

(3028433) Virus identified in Specimen by Culture

249

1.55

1.86

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

419

3657

1.14

1.85

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method

580

5165

1.12

1.85

2.8

2.9

—

(3000764) Benzodiazepines [Presence] in Urine

822

7455

1.10

1.85

2.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

224

2625

0.84

1.83

5.9

7.0

mmol/l

24.1

24.3

0.27

207

2454

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

165

1336

1.23

1.79

1.2

1.1

118.4

115.9

0.47

149

1223

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

365

1.44

1.78

1.9

1.8

mg/l

2.9

3.3

0.35

350

(3008536) Aspergillus sp Ab [Presence] in Serum

122

1.79

1.78

2.0

3.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

575

5138

1.11

1.74

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

723

1.30

1.74

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

249

2104

1.18

1.72

1.7

2.1

iu/l

39.2

4.3

0.49

869

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

241

2032

1.18

1.71

1.3

1.6

u/ml

97.2

105.3

0.61

376

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

845

7705

1.09

1.71

2.4

u/l

6695.6

6318.7

0.12

327

3050

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

146

1174

1.23

1.71

1.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

452

1.38

1.70

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

452

1.38

1.70

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

452

1.38

1.70

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

572

5118

1.11

1.70

1.4

—

(3016879) Cocaine [Presence] in Urine

762

6918

1.10

1.70

2.1

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

649

5846

1.11

1.70

2.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

110

1.80

1.67

1.0

1.1

umol/24h

0.6

0.7

0.78

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1017

9359

1.08

1.67

1.6

1.5

—

(3003694) ABO and Rh group [Type] in Blood

2482

25588

0.94

1.66

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

155

1.66

1.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3444

32977

1.05

1.64

3.8

3.9

—

(40761535) Cells panel - Urine sediment

497

4423

1.12

1.64

3.2

—

(3045414) Leukocytes [Presence] in Urine

342

2974

1.14

1.63

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

210

1.56

1.63

2.0

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

210

1.56

1.63

2.0

2.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

584

1.32

1.62

1.5

1.7

42.6

52.3

1.32

377

(3033799) Differential panel - Peritoneal fluid

130

0.38

1.62

1.0

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

102

793

1.28

1.61

1.4

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

119

944

1.25

1.59

3.2

3.3

mu/l

41.1

26.0

1.25

109

888

(3000330) Specific gravity of Urine by Test strip

224

2589

0.85

1.59

2.5

2.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.91

1.59

1.9

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

416

1.38

1.59

1.1

nmol/l

0.1

3.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

971

1.25

1.59

1.4

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

612

1.31

1.59

1.7

1.8

—

(3037121) Protein [Mass/volume] in Urine

259

2213

1.16

1.59

3.1

4.1

g/l

0.4

0.02

100

1140

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

104

813

1.27

1.58

1.3

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

137

1106

1.23

1.57

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

606

1.31

1.55

2.7

3.5

—

(3003181) Sodium [Moles/volume] in Urine

728

1.28

1.54

1.8

mmol/l

64.4

70.3

0.50

603

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

572

5150

1.11

1.53

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

105

826

1.26

1.52

2.9

3.1

0.7

1.3

2.71

663

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

117

1429

0.81

1.52

3.2

3.7

u/ml

127.1

1204.8

0.88

100

1223

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

572

5154

1.10

1.51

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

626

1.30

1.51

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

951

10086

0.93

1.51

1.5

—

(4281824)

614

0.71

1.51

1.1

—

(3000991) Gas panel - Venous blood

571

5147

1.10

1.50

7.5

9.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

413

3658

1.12

1.50

4.8

6.1

mmol/l

24.2

24.0

0.49

381

3412

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.01

1.50

1.1

—

3.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

515

4619

1.11

1.49

7.2

8.0

mmol/l

1.3

0.59

489

4417

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

100

785

1.26

1.48

1.4

1.5

pmol/l

352.2

386.5

0.19

631

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

124

998

1.23

1.48

1.7

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1054

9775

1.08

1.44

2.1

2.0

—

(3027944) Amphetamines [Presence] in Urine

807

7407

1.09

1.44

1.8

2.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

476

1.33

1.43

1.2

—

(3020491) Glucose [Moles/volume] in Blood

545

1.31

1.42

1.5

mmol/l

6.5

6.0

0.48

430

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.09

1.42

1.4

3.8

—

(3044290) Cell count panel - Cerebral spinal fluid

209

1777

1.17

1.40

1.2

1.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.95

1.39

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

148

1.61

1.38

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

532

1.30

1.36

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

103

1.73

1.36

1.7

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

113

1365

0.82

1.36

1.4

1.5

mmol/l

6.3

6.7

1.06

974

(3022475) Manganese [Moles/volume] in Blood

2.05

1.34

1.5

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

270

1.43

1.34

1.3

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.75

1.34

1.5

1.4

—

166.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

111

1.69

1.34

1.1

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

111

1.69

1.34

1.1

1.8

ng/l

90.4

30.1

0.51

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

167

1402

1.18

1.32

1.7

1.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

135

1.61

1.30

1.1

2.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

694

1.26

1.29

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

165

1388

1.18

1.28

1.1

iu/ml

109.4

7026.9

0.64

386

(44806071)

128

1.62

1.28

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

923

8562

1.07

1.28

1.4

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

170

1435

1.18

1.27

1.3

u/ml

3.9

0.00

511

(3051651) Icteric interference index of Serum or Plasma

443

1.32

1.27

2.5

3.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

187

1593

1.16

1.25

5.6

6.6

iu/ml

1142.9

570.5

0.52

196

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

453

1.31

1.24

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

436

1.32

1.24

1.2

1.1

—

(3049717) Cytology report of Urine Cyto stain

135

1120

1.20

1.24

2.1

2.2

—

(3047181) Lactate [Moles/volume] in Blood

131

1543

0.84

1.23

4.2

5.7

mmol/l

1.2

0.44

115

1351

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

700

1.25

1.22

1.4

1.3

u/l

20.1

29.8

0.77

600

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

106

862

1.22

1.20

2.0

1.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.60

1.20

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

142

0.49

1.20

2.4

5.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

1029

0.81

1.19

2.9

3.3

—

(3036603) Volume of Urine

371

1.34

1.18

1.7

1.5

2790.5

2209.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

161

1364

1.17

1.18

3.0

mg/l

23.3

24.5

0.14

838

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.28

1.17

2.2

2.0

—

(3013762) Body weight Measured

0.00

1.16

0.0

1.2

—

(3044007) Cell count panel - Peritoneal fluid

127

0.47

1.16

2.2

2.0

—

(3001729) Color of Synovial fluid

0.00

1.15

0.0

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

176

1505

1.16

1.15

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.47

1.13

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.91

1.13

1.4

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.91

1.13

1.1

umol/24h

1.4

1.7

0.49

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

989

0.81

1.12

2.7

3.6

u/ml

5.0

37.6

1.08

886

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

718

1.23

1.11

1.1

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

629

1.24

1.11

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

127

1061

1.19

1.11

1.1

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

603

5540

1.08

1.11

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

136

0.51

1.09

2.4

5.4

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.36

1.07

1.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

268

2371

1.12

1.07

4.2

6.2

kpa

9.4

0.16

255

2250

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

167

1.48

1.07

1.0

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

156

1334

1.16

1.04

2.7

4.2

mmol/l

23.6

24.0

0.81

144

1195

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

437

0.72

1.04

1.3

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

108

1270

0.84

1.04

3.7

4.1

mmol/l

3.8

0.17

102

1189

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

727

0.79

1.03

8.9

11.6

mmol/l

0.6

0.53

664

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

218

1.41

1.03

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

213

0.60

1.02

1.8

2.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

258

2846

0.89

1.02

1.9

2.6

e6/l

0.2

0.19

248

2740

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

771

1.21

1.02

1.2

1.3

nmol/l

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.25

1.02

1.2

2.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.04

1.01

1.4

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

2.04

1.01

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

495

1.26

1.01

1.4

nmol/l

1.5

1.4

0.39

445

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.90

1.01

2.3

—

(40768795) Lymph node Pathology biopsy report

569

0.76

1.01

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

469

1.27

1.01

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

445

0.73

1.00

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

656

1.22

1.00

1.2

1.3

mmol/l

1.7

1.8

1.72

605

(3008295) Osmolality of Serum or Plasma

656

1.22

1.00

2.5

1.7

mosm/kgh2o

283.1

285.7

0.46

517

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.87

0.98

1.5

1.2

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.97

0.0

1.9

—

0.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

131

1.51

0.95

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

769

1.20

0.95

1.4

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

751

1.20

0.95

1.7

1.9

91.7

91.1

0.64

741

(40760409) HLA-A [Type] by High resolution

0.00

0.94

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.94

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.94

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.94

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.94

0.0

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

284

2544

1.11

0.94

1.2

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

264

2891

0.90

0.94

4.6

4.3

g/l

135.0

132.3

1.25

256

2835

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

698

1.21

0.93

1.6

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

450

0.75

0.93

2.8

2.9

mg/l

81.5

78.0

0.03

341

(3040893) Potassium [Moles/volume] in Capillary blood

2.20

0.93

1.3

3.2

mmol/l

4.2

4.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

310

2793

1.10

0.92

2.5

3.7

95.4

94.4

0.32

291

2613

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

116

1.54

0.92

1.4

1.1

—

(3021901) Oxygen saturation in Capillary blood

109

917

1.18

0.92

2.8

3.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

107

899

1.18

0.92

1.6

2.0

mmol/l

1.6

1.7

1.08

107

882

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.12

0.91

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

250

1.35

0.90

1.5

1.6

—

(3018572) Chloride [Moles/volume] in Blood

972

0.83

0.90

5.0

7.4

mmol/l

105.9

105.5

0.48

870

(3023183) Ammonium ion [Moles/volume] in Plasma

106

1228

0.85

0.89

3.2

3.1

umol/l

34.9

34.6

0.04

1091

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

226

2007

1.12

0.89

1.8

2.0

g/l

1.3

1.4

1.05

195

1722

(3039000) Anion gap in Blood

971

0.83

0.89

5.0

7.5

mmol/l

11.6

11.3

0.43

869

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.80

0.89

1.0

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

449

4782

0.93

0.88

7.6

9.1

mmol/l

6.9

7.1

0.25

426

4618

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

129

0.54

0.87

8.1

8.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.73

0.87

1.4

2.1

u/field

0.6

0.9

0.28

(3020876) Protein [Mass/time] in 24 hour Urine

356

1.28

0.86

2.1

g/24h

0.8

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

304

1.30

0.86

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

363

3891

0.92

0.85

3.2

4.0

ug/l

4.8

28.1

1.68

258

2884

(3027923) C peptide [Moles/volume] in Serum or Plasma

305

1.30

0.84

2.1

nmol/l

1.8

1.4

1.10

254

(3021447) Carbon dioxide [Partial pressure] in Venous blood

591

5495

1.07

0.84

4.4

5.5

kpa

5.8

5.9

0.18

565

5330

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.76

0.83

1.1

1.2

—

(3004451) EKG impression Narrative

178

1.39

0.81

1.3

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

316

1.28

0.81

1.8

1.7

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.86

0.80

1.0

—

8.3

—

(4133840)

221

1.34

0.80

1.0

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.68

0.79

3.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

196

1.36

0.79

1.4

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

127

1098

1.15

0.79

2.6

3.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

154

1.41

0.79

1.5

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

121

1.47

0.79

3.0

2.6

—

(3034988) Calcium [Moles/volume] in Capillary blood

148

0.60

0.78

1.1

5.0

mmol/l

1.2

—

136

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

841

1.17

0.78

1.5

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

632

1.19

0.77

1.3

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

407

1.24

0.77

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

372

1.25

0.76

1.6

—

(3002032) Base excess in Venous blood by calculation

584

5451

1.06

0.76

4.4

5.5

mmol/l

1.7

1.6

0.34

484

4392

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.65

0.76

1.0

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

154

1354

1.13

0.76

1.3

—

(3012565) Volume of 24 hour Urine

311

1.27

0.75

2.0

2.2

2297.3

2031.6

0.75

290

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2236

21546

1.04

0.75

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

735

1.17

0.74

1.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

1015

0.86

0.74

8.5

5.5

65.7

65.6

0.03

1010

(3011648) Oxygen content in Venous blood

520

0.80

0.74

7.8

7.5

11.5

11.3

0.11

520

(3022217) INR in Platelet poor plasma by Coagulation assay

527

4911

1.07

0.73

14.0

13.8

inr

1.2

1.1

0.59

838

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

278

1.28

0.72

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

233

2104

1.10

0.72

1.3

1.7

mg/l

403.8

455.0

0.98

223

2007

(4034850)

215

1935

1.10

0.71

6.7

7.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1386

13256

1.04

0.70

2.1

—

(40757373) Influenza virus identified in Isolate

108

1.47

0.70

1.8

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.90

0.70

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

132

1157

1.13

0.70

2.5

2.4

17.4

17.3

0.03

582

(21494890) Protein electrophoresis panel - 24 hour Urine

315

1.26

0.69

2.5

2.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.60

0.69

1.0

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

142

1.39

0.68

3.5

3.7

u/l

45.3

84.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

317

1.25

0.66

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

229

1.30

0.66

2.4

2.5

mmol/l

1.4

1.6

0.25

176

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.58

0.65

2.5

2.0

mmol/l

5.7

7.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

152

1.37

0.65

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

152

1.37

0.65

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

318

1.25

0.65

1.4

1.8

nmol/l

0.2

1.01

237

(3009466) Valproate [Moles/volume] in Serum or Plasma

107

1200

0.88

0.64

5.3

5.6

umol/l

364.6

383.3

0.80

1063

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

619

1.17

0.63

1.2

1.1

ratio

1.1

0.25

227

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

546

1.18

0.63

4.6

3.9

mg/l

9.1

8.1

0.58

434

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

111

1.43

0.62

1.4

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.56

0.62

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

330

1.23

0.61

1.3

1.2

u/l

82.9

83.5

0.02

292

(3029396) Erythrocyte agglutination [Presence] in Blood

517

0.82

0.61

3.4

3.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1048

0.88

0.61

2.4

2.6

ug/min

77.5

133.8

0.93

684

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

430

0.80

0.61

5.6

7.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.58

0.60

3.6

3.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.65

0.60

1.6

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

112

1.41

0.60

1.1

1.3

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.60

0.0

6.1

—

930.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

198

1.30

0.60

1.0

ng/l

849.8

819.0

0.18

136

(3007916) DNA double strand Ab [Titer] in Serum

1.50

0.60

1.3

—

332.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.60

0.0

6.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

242

1.27

0.60

1.3

1.4

umol/l

17.5

17.0

0.30

221

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

504

1.18

0.59

2.8

3.2

au/ml

107.6

143.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

428

0.81

0.59

3.3

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

428

0.81

0.59

6.6

6.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.58

0.0

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

205

1865

1.09

0.58

1.2

1.6

mmol/l

3.5

3.6

1.42

194

1749

(3029612) Listeria sp Ab [Titer] in Serum

1.70

0.57

1.2

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

783

1.14

0.57

1.4

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

253

1.25

0.56

1.4

1.9

—

19581.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

200

1.29

0.56

1.0

ng/l

41.5

41.2

0.01

138

(4268621)

112

989

1.12

0.56

2.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

654

6761

0.95

0.56

1.4

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.57

0.56

1.0

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.56

0.55

1.2

1.1

—

3.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.45

0.55

1.2

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.60

0.55

1.2

1.4

nmol/l

359.5

521.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

303

0.78

0.54

7.5

6.0

mg/l

7972.7

543.6

0.44

234

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

246

1.25

0.54

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

246

1.25

0.54

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

246

1.25

0.54

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2129

20618

1.03

0.54

2.6

2.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.48

0.54

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.56

0.53

1.2

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.56

0.53

6.5

5.3

—

(3041354) Potassium [Moles/volume] in Venous blood

422

0.82

0.53

1.5

2.2

mmol/l

4.0

3.9

0.39

417

(3043410) Blood group antigens tested for on Red Blood Cells

191

0.72

0.53

1.8

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

411

0.82

0.53

1.6

2.9

umol/l

98.1

177.5

1.81

219

(3024928) Oxygen saturation in Venous blood

107

1180

0.90

0.52

7.4

5.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

312

0.79

0.52

1.5

1.4

e6/l

2392.1

2831.7

0.17

212

(3022621) pH of Urine by Test strip

443

4164

1.06

0.51

2.4

2.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

212

1.26

0.51

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

420

0.82

0.51

1.5

2.2

mmol/l

107.4

105.7

2.31

415

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

420

0.82

0.51

2.5

2.6

umol/l

56.9

53.0

0.34

375

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

212

0.75

0.51

2.9

1.7

—

513.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

248

1.24

0.51

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

333

0.80

0.51

1.0

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

125

1.35

0.50

1.2

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.41

0.50

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

550

1.15

0.50

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

339

1.20

0.50

1.5

1.6

u/l

7.9

5.1

0.27

180

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

211

0.75

0.50

2.8

2.5

—

(3020650) Glucose [Presence] in Urine

233

0.76

0.49

1.2

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

450

1.17

0.48

1.3

1.6

41.0

38.3

0.17

279

(3005082) Progesterone [Moles/volume] in Serum or Plasma

985

0.89

0.48

1.4

nmol/l

34.8

31.4

0.61

906

(3042733) HLA Ab [Presence] in Serum

297

0.80

0.47

6.6

4.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1109

10659

1.03

0.47

2.0

1.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

305

1.20

0.47

1.1

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

108

965

1.11

0.47

1.4

1.5

mmol/l

10.6

11.9

0.46

149

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2829

27548

1.02

0.47

3.0

3.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

844

1.11

0.46

1.1

mg/l

211.8

224.9

0.56

741

(3011048) Pyruvate [Moles/volume] in Blood

110

1.35

0.46

1.1

1.3

umol/l

102.8

85.6

0.38

102

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

416

1.17

0.46

1.1

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.60

0.45

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

307

1.19

0.45

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

495

4691

1.05

0.44

4.0

5.3

kpa

4.9

0.06

474

4542

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

173

0.74

0.44

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

381

1.17

0.44

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

530

5462

0.96

0.44

2.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

240

2230

1.07

0.43

1.5

nmol/l

0.4

0.05

204

1811

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

130

1400

0.92

0.43

1.4

1.5

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.60

0.42

1.8

1.1

mg/l

0.0

—

(40761536) Microorganisms panel - Urine sediment

680

6496

1.04

0.42

3.6

3.3

—

(3028717) Thiamine [Mass/volume] in Blood

0.66

0.42

1.3

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

0.66

0.42

1.0

1.4

62.3

56.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

616

1.13

0.41

1.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

215

0.78

0.41

1.2

1.0

mmol/l

19.7

19.8

0.07

200

(3006598) pH of Arterial cord blood

193

0.77

0.41

1.1

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

193

0.77

0.41

1.1

1.0

—

0.8

—

(3020891) Body temperature

171

1817

0.93

0.41

3.8

4.8

—

(21494434) Karyotype in Bone marrow

393

1.16

0.41

1.3

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

109

984

1.10

0.41

1.3

1.8

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

0.00

0.41

0.0

1.2

—

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

139

1.28

0.41

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

139

1.28

0.41

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

139

1.28

0.41

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

139

1.28

0.41

1.3

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

0.00

0.40

0.0

1.2

—

34.5

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.40

0.0

1.2

—

1.7

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.40

0.0

1.1

—

210.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

302

1.18

0.40

1.3

1.5

pmol/l

13.7

14.2

0.32

256

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

872

1.10

0.40

1.2

mg/l

31.4

37.5

1.44

719

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

487

1.14

0.40

1.2

u/ml

11.9

18.8

—

(44790049)

797

1.11

0.40

1.4

1.7

—

(44790047)

797

1.11

0.40

1.4

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

835

1.10

0.39

1.1

—

(44806118)

798

1.10

0.39

1.4

1.7

—

(44790048)

798

1.10

0.39

1.4

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

140

1.27

0.39

7.6

4.3

—

(3016750) Collection duration of Urine

278

0.82

0.39

1.4

2.3

min

518.4

506.9

0.20

223

(3033705) Calcium.ionized [Moles/volume] in Venous blood

406

0.85

0.39

1.5

2.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.41

0.39

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

108

980

1.09

0.38

1.1

—

71.6

—

(3017569) Oxygen content in Arterial blood

168

0.77

0.37

1.8

2.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

406

1.15

0.37

1.4

e6/l

22772.4

44494.5

0.53

290

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

457

0.87

0.37

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

323

1.16

0.37

1.3

1.2

u/l

13.3

18.2

0.69

283

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

113

1029

1.09

0.37

1.7

1.8

—

(4035726)

450

4630

0.96

0.37

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

759

0.90

0.36

1.5

1.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

333

1.16

0.36

2.0

1.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.45

0.35

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.65

0.35

1.0

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

334

1.16

0.35

1.3

1.6

u/field

1.0

3.4

2.28

247

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

133

0.74

0.35

1.0

1.1

—

(4027681)

700

1.10

0.35

1.2

1.3

—

(3022689) Creatine [Moles/volume] in Urine

165

0.78

0.34

1.5

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

132

0.75

0.34

1.2

4.9

mmol/l

1.2

—

119

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

132

0.75

0.34

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

117

1247

0.93

0.33

1.2

1.3

—

(3004775) Volume in Urine collected for unspecified duration

336

0.85

0.33

1.8

2.4

667.9

620.7

0.25

254

(3026008) Bacteria identified in Urine by Culture

1849

18000

1.02

0.33

2.5

2.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.29

0.32

1.2

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

335

0.86

0.32

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

117

1245

0.93

0.32

3.5

5.9

u/ml

0.4

0.3

0.86

689

(3005033) Fetal Nuchal fold Thickness US

430

4104

1.04

0.32

1.4

1.5

—

(3017704) Immunofixation for Urine

172

1.21

0.31

1.7

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

431

4115

1.04

0.31

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

210

1972

1.05

0.31

1.2

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

438

0.88

0.30

1.1

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

213

2217

0.95

0.30

5.0

4.2

0.7

0.67

203

2143

(3002173) Hemoglobin [Mass/volume] in Arterial blood

400

4102

0.96

0.30

7.8

8.9

g/l

125.2

123.8

0.66

390

3963

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

368

1.13

0.29

1.1

1.2

—

(4038314)

110

1.26

0.29

1.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

440

4210

1.04

0.29

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

229

1.17

0.29

4.9

3.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

142

1491

0.94

0.28

1.5

1.6

mmol/l

7.3

7.5

0.73

900

(3012898) Urea [Moles/volume] in Urine

1.32

0.28

1.9

1.8

mmol/l

220.7

178.1

—

(3025130) Human papilloma virus identified in Specimen

168

1574

1.06

0.28

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

1.30

0.28

1.4

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

108

998

1.07

0.27

1.1

—

19.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1910

18640

1.02

0.27

3.4

estimate

0.0

0.13

682

6944

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

247

2551

0.96

0.27

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

531

1.10

0.27

2.5

2.2

—

(3000012) Reticulocyte production index

245

0.85

0.27

1.1

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

115

0.77

0.27

3.7

5.9

—

(3045788) Cell count panel - Pleural fluid

255

0.85

0.27

1.6

1.5

—

(40768446) Kidney Pathology biopsy report

338

0.88

0.26

1.8

1.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

385

3933

0.97

0.25

2.3

2.6

u/ml

31.6

37.4

0.45

374

3804

(40768793) Breast Pathology biopsy report

158

1484

1.05

0.25

1.2

1.3

—

(3017509) Phencyclidine [Presence] in Urine

186

1.17

0.25

1.6

1.9

—

(3014051) Protein [Presence] in Urine by Test strip

142

1483

0.95

0.25

2.0

1.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

602

1.09

0.24

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.17

0.24

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.73

0.24

1.3

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

432

1.10

0.23

1.4

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

220

2266

0.96

0.23

4.9

4.3

1.4

0.01

220

2252

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

123

1.21

0.23

1.2

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

133

1248

1.06

0.23

3.1

4.7

u/ml

1795.5

1019.6

—

(3023410) Appearance of Cerebral spinal fluid

104

969

1.06

0.23

1.4

2.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.27

0.22

2.0

1.3

—

(3016502) Oxygen saturation in Arterial blood

453

4364

1.03

0.22

7.3

8.7

95.4

96.2

1.05

436

4208

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

198

1879

1.04

0.22

1.3

1.8

e6/l

15.6

24.3

0.59

151

1444

(3020393) Adenovirus Ag [Presence] in Stool

207

1.15

0.22

1.3

1.7

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.24

0.22

1.8

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.24

0.22

2.4

2.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.24

0.22

1.4

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

208

0.86

0.22

1.1

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

198

1880

1.04

0.22

1.3

1.8

e6/l

436.8

3167.2

0.77

159

1516

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

273

1.12

0.22

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

155

0.83

0.22

1.2

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

155

0.83

0.22

1.2

2.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

740

1.07

0.22

1.3

1.6

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.21

0.21

1.8

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

144

0.82

0.21

1.8

4.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

283

1.12

0.21

1.6

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.21

0.0

1.0

—

1.1

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.21

0.0

3.3

—

139.3

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.20

0.0

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

100

935

1.06

0.20

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

3.1

—

(3035880) pH of Pleural fluid

116

1.19

0.20

1.1

1.3

—

(1761868) Lipid panel - Serum or Plasma

2912

28585

1.01

0.20

2.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.21

0.20

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

114

0.78

0.20

1.2

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.19

0.19

2.3

1.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

668

0.93

0.19

2.5

4.7

mmol/l

7.6

7.1

0.40

547

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

241

2307

1.03

0.19

4.2

8.7

mg/l

1.2

0.43

228

2220

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

185

1762

1.04

0.19

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

163

0.85

0.19

2.4

2.0

ug/l

2.7

2.9

0.09

145

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

126

1.18

0.19

1.5

nmol/l

21.6

16.5

—

(21494755) Public health laboratory ask at order entry panel

1138

11414

0.98

0.19

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.14

0.19

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1743

17426

0.99

0.18

1.6

1.5

—

(3025577) Chromium [Mass/volume] in Blood

162

0.85

0.18

2.4

2.0

ug/l

2.1

2.6

0.39

141

(3006653) Thiamine [Moles/volume] in Blood

325

1.10

0.18

1.4

nmol/l

130.3

132.4

0.13

325

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

193

0.87

0.17

1.5

2.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

278

1.10

0.17

1.5

2.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

278

1.10

0.17

1.5

2.4

—

(40768806) Pleura Pathology biopsy report

265

0.90

0.17

1.5

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.75

0.17

6.4

7.4

mmol/l

5.6

6.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.20

0.16

1.1

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.11

0.16

1.3

1.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

139

0.85

0.15

1.2

1.8

ug/l

1.9

2.0

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.79

0.15

1.0

1.4

27.3

27.8

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

0.78

0.15

1.0

1.4

5.2

3.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

169

1617

1.03

0.15

1.7

—

(3002619) Bacteria identified in Specimen by Culture

157

1.13

0.15

1.2

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

101

1.18

0.15

2.6

2.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

146

1395

1.04

0.14

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

465

4518

1.02

0.14

2.5

2.4

ml/min/173m2

81.6

78.2

1.11

201

1600

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

148

0.87

0.14

1.1

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

435

0.93

0.14

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

340

3435

0.98

0.14

1.4

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

330

1.08

0.14

1.6

2.4

ng/l

177.3

127.3

1.64

255

(3019060) Gas panel - Arterial blood

256

2594

0.98

0.13

3.7

5.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

252

2435

1.02

0.13

8.9

11.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

169

1.11

0.12

1.2

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

651

1.05

0.12

1.6

2.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

208

0.90

0.12

1.1

1.2

—

(3024263) Appearance of Synovial fluid

246

1.09

0.12

1.8

2.1

—

(40758292) HTLV I+II Ab panel - Serum

160

1.11

0.12

1.7

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

802

0.96

0.10

3.2

4.4

u/ml

119.6

87.1

0.16

262

(3012441) Differential panel - Pleural fluid

267

0.93

0.10

1.4

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

200

1.09

0.10

2.8

2.7

umol/l

25.9

29.1

0.76

140

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

306

1.07

0.10

1.1

—

(40768800) Prostate Pathology biopsy report

358

0.94

0.10

1.1

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.05

0.09

1.2

1.3

—

(3024471) HLA-A [Type]

306

0.94

0.09

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

175

1694

1.02

0.09

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

148

1499

0.98

0.09

1.8

2.0

ug/l

1.2

1.9

1.24

130

1346

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

395

1.05

0.09

1.4

2.0

u/field

1.8

1.9

0.06

212

(3049233) Organic acids panel - Urine

1.10

0.09

1.0

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

416

0.95

0.08

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

224

0.93

0.08

2.8

2.7

—

(40768441) Liver Pathology biopsy report

532

1.04

0.08

1.2

1.5

—

(3036048) Francisella tularensis Ab [Titer] in Serum

202

1.08

0.08

1.0

1.1

—

180.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.02

0.08

1.5

1.1

—

(3000285) Sodium [Moles/volume] in Blood

0.81

0.08

1.0

1.1

—

(3024932) HLA-DR beta [Type]

304

0.94

0.08

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

290

1.06

0.07

2.1

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1801

17902

0.99

0.07

1.7

1.8

—

(44806420)

0.85

0.07

1.8

2.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

339

1.05

0.07

3.0

3.1

nmol/l

0.8

0.06

263

(3003338) MCHC [Mass/volume]

7049

69826

0.99

0.07

13.2

12.9

g/l

333.9

333.6

1.31

6996

69257

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.06

0.07

2.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

273

0.94

0.07

1.4

1.5

e6/l

6575.9

45500.4

1.40

154

(3019150) Specific gravity of Urine by Refractometry

1584

15595

1.01

0.07

3.1

3.3

kg/l

1.0

0.03

227

2248

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.01

0.07

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

202

0.93

0.07

2.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

131

0.91

0.07

1.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

605

6036

0.99

0.07

7.0

7.6

mmol/l

104.8

104.7

0.14

598

5923

(3045142) Bone marrow Pathology biopsy report

535

1.04

0.07

1.5

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

457

1.04

0.07

1.0

100.6

92.3

1.02

369

(3047189) Immunofixation for 24 hour Urine

146

1.08

0.06

3.6

1.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

100

0.89

0.06

1.1

—

(4198724)

820

1.03

0.06

2.2

2.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.11

0.06

2.5

1.9

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

189

1897

0.99

0.06

1.4

pmol/l

66.7

102.9

1.50

183

1847

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

134

1349

0.98

0.05

2.5

2.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

170

0.93

0.05

4.0

6.0

mmol/l

23.1

24.7

1.21

163

(3027273) Bicarbonate [Moles/volume] in Venous blood

209

2094

0.99

0.05

3.0

3.8

mmol/l

25.4

25.1

0.59

195

2019

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

220

0.94

0.05

1.0

1.1

—

(3018133) Calcium [Moles/volume] in Urine

274

1.05

0.05

3.3

3.0

mmol/l

2.9

2.8

0.17

256

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

310

0.96

0.05

1.6

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

206

1.06

0.05

2.1

2.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

129

0.92

0.05

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

506

4974

1.01

0.04

7.2

8.1

kpa

13.1

13.8

2.13

480

4765

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

422

1.03

0.04

1.2

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

506

4975

1.01

0.04

7.2

8.1

kpa

5.0

5.1

0.41

481

4766

(3010937) Rubella virus Ab [Presence] in Serum

1.10

0.04

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

118

0.92

0.04

1.1

4.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

747

1.02

0.04

1.5

promille

1.4

1.3

0.16

565

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

218

0.95

0.04

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

258

2531

1.01

0.04

1.2

1.3

ug/l

4.0

0.01

242

2375

(21491868) Cryoglobulin [Mass/volume] in Serum

247

1.04

0.03

1.1

1.2

—

0.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

208

1.05

0.03

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

506

0.98

0.03

1.3

1.6

—

(3019977) pH of Arterial blood

237

0.96

0.03

1.2

2.9

7.4

—

(3022229) Phosphate [Moles/volume] in Urine

157

0.95

0.03

4.1

2.9

mmol/l

27.1

19.6

1.21

143

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

438

4314

1.00

0.02

3.1

3.6

mmol/l

1.2

0.23

391

3764

(3003396) Base excess in Arterial blood by calculation

506

4987

1.00

0.02

7.2

8.1

mmol/l

0.6

0.7

0.42

410

3813

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

534

0.98

0.02

1.1

miu/ml

1280.9

1503.9

0.99

534

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

135

1347

0.99

0.02

1.6

2.7

nmol/l

0.9

0.8

0.54

111

1158

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.08

0.02

1.5

1.6

ng/l

121.7

88.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

555

1.02

0.02

1.2

1.1

u/l

1.0

0.34

239

(3036782) Glucose [Moles/volume] in Pleural fluid

279

1.03

0.02

1.3

mmol/l

6.5

6.1

0.33

257

(3032868) Hemoglobin electrophoresis panel in Blood

125

0.95

0.01

1.5

1.6

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

152

1.04

0.01

1.3

2.2

nmol/l

1.9

4.2

1.07

140

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

115

0.95

0.01

1.5

1.2

—

(3015183) Erythrocyte sedimentation rate

541

0.99

0.01

1.3

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

144

0.96

0.00

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

130

0.99

0.00

1.2

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

223

0.98

0.00

1.1

—

(40765096) Chromosome analysis panel by Banding

154

1.03

0.00

1.3

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

166

1.01

0.00

1.9

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

436

1.00

0.00

2.5

2.8

45.5

43.4

0.31

142

(3016228) CD19 cells/100 cells in Blood

294

1.01

0.00

2.2

8.6

9.2

0.16

288

(3034426) Prothrombin time (PT)

319

0.99

0.00

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

222

0.98

0.00

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

715

1.00

0.00

2.9

3.7

u/ml

158.4

630.7

0.70

665

(3013727) Leukocytes other/100 leukocytes in Blood

186

1.01

0.00

5.9

3.7

50.2

47.7

0.23

181

(40761539) Cells [Type] in Urine sediment by Light microscopy

140

0.99

0.00

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

140

0.99

0.00

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

118

1.01

0.00

1.5

1.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

629

1.01

0.00

1.2

1.6

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.97

0.00

2.4

1.2

—

551.4

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.6

—

723.3

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

2.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.94

0.00

1.0

1.1

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

2.1

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

6.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.99

0.00

1.0

1.2

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

52.3

—

(3007463) Buprenorphine [Presence] in Urine

0.99

0.00

4.4

4.8

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint POLLENALLERG and mortality.

Females

Parameter	HR [95% CI]	p-value
POLLENALLERG	0.829 [0.7, 0.98]	0.031
Birth year	0.998 [0.99, 1.01]	0.672

During the follow-up period (1.1.1998 — 31.12.2019), 503 out of 42785 females with POLLENALLERG died.

Males

Parameter	HR [95% CI]	p-value
POLLENALLERG	0.69 [0.59, 0.81]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.052

During the follow-up period (1.1.1998 — 31.12.2019), 571 out of 48491 males with POLLENALLERG died.

Mortality risk

Mortality risk for people of age

years, who have POLLENALLERG.

N-year risk	Females	Males
1	0.073%	0.129%
5	0.511%	0.928%
10	1.317%	2.246%
15	2.714%	4.4%
20	4.576%	7.364%

Relationships between endpoints

↥

Index endpoint: POLLENALLERG – Pollen allergy

GWS hits: 9

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pollen allergy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints